Feinstein Partners, Inc.

May 18, 09 NEW STORY 07:00 ET Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes   Dec 22, 08 06:00 ET Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer   Nov 25, 08 12:44 ET Gene Network Sciences Announces Creation of Spin-off Entity Focused on Quantitative Finance and E-Commerce   Nov 12, 08 08:00 ET US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period   Oct 28, 08 07:30 ET Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability   Oct 27, 08 16:02 ET Monogram Announces a 6-to-1 Reverse Stock Split   Oct 26, 08 11:30 ET Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay   Oct 23, 08 18:15 ET Monogram Announces Conference Call   Oct 22, 08 08:00 ET VeraTag(TM) Assays Featured at EORTC-NCI-AACR Symposium   Oct 15, 08 08:30 ET Stem Cell Trendsetters in Neurology and Psychiatry Analyzed by NeuroInsights   Oct 07, 08 05:00 ET Monogram Reaffirms Guidance for Year and Provides Update on Oncology Programs   Oct 03, 08 16:30 ET Monogram Receives NASDAQ Notification   Oct 01, 08 07:30 ET Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec   Sep 29, 08 13:25 ET Monogram Biosciences to Present at the JMP Securities Healthcare Conference   Sep 23, 08 07:00 ET Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer   Sep 19, 08 10:48 ET Academy Award Winner Louis Gossett Jr. Joins Tens of Thousands of Americans Rallying in 80 Communities, Celebrating Recovery from Addiction   Sep 18, 08 08:00 ET IDIS to Sponsor Inaugural Conference on Pre-Launch Access to Drugs   Sep 17, 08 08:00 ET Tethys Bioscience Announces Acquisition of Lipomics Technologies   Sep 15, 08 06:00 ET Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer   Aug 26, 08 07:00 ET IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs   Aug 25, 08 12:12 ET First Major Medical Meeting Convening for MRI-guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions   Aug 21, 08 09:00 ET Monogram Appoints Oncologist to Board of Directors   Aug 20, 08 09:00 ET Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.   08:45 ET Alzheimer's Disease and Emerging Treatments Analyzed in Neurotech Insights   Aug 13, 08 09:58 ET John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients'   Aug 11, 08 08:02 ET InterWest Partners Announces Closing of $650 Million Venture Fund   Aug 07, 08 15:12 ET Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008   14:30 ET Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads   13:30 ET Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients   Aug 06, 08 13:05 ET Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy   Aug 04, 08 08:30 ET Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors   Jul 29, 08 15:49 ET Monogram Announces 2008 Second Quarter Financial Results   Jul 23, 08 06:00 ET Monogram Announces Issuance of Key Patents Related to VeraTag(TM) Technology   Jul 16, 08 13:15 ET Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call   Jul 08, 08 08:00 ET Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day   04:00 ET Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay   Jul 01, 08 06:00 ET Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference   Jun 18, 08 06:00 ET Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies   Jun 17, 08 05:07 ET Organizing Tips for the ADHD Family   Jun 16, 08 06:00 ET Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy   Jun 07, 08 13:09 ET Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test   Jun 05, 08 06:00 ET Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay   Jun 02, 08 14:45 ET Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting   May 29, 08 09:00 ET Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning   May 20, 08 10:45 ET Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone   10:45 ET Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation   09:15 ET Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients   May 16, 08 12:02 ET Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting   09:31 ET Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008   May 08, 08 07:00 ET Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007   May 07, 08 15:26 ET Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness   May 01, 08 16:11 ET HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics   16:00 ET Monogram Announces 2008 First Quarter Financial Results   Apr 21, 08 13:30 ET Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call   Apr 15, 08 16:45 ET FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment   Apr 14, 08 21:30 ET Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference   Apr 08, 08 06:04 ET Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers   06:02 ET Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments   06:00 ET Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health   06:00 ET New York Medicaid Program Establishes Coverage for Trofile(TM)   Apr 07, 08 06:00 ET Prestigious Scientific Leaders Join InterWest Advisory Committee   Apr 01, 08 06:00 ET Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials   Mar 31, 08 06:00 ET Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program   Mar 25, 08 06:00 ET Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology   Mar 19, 08 06:00 ET Stephen Holmes of InterWest Appointed to Prestigious Venture Capital Valuation Board   Mar 17, 08 02:00 ET California Medicaid Establishes Coverage for Trofile(TM)   Mar 10, 08 09:00 ET Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts   Feb 11, 08 10:01 ET Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008   Feb 07, 08 16:00 ET Monogram Announces 2007 Year-End Financial Results   06:00 ET Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity   Feb 04, 08 06:00 ET DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use   Jan 30, 08 19:39 ET Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call   Jan 09, 08 14:52 ET Dey, L.P. Settles State of Alabama Pricing Litigation   Dec 19, 07 16:00 ET Study Reaffirms Superiority of Trofile(TM) Assay   Dec 14, 07 08:00 ET HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium   Dec 10, 07 06:00 ET Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium   Nov 29, 07 08:30 ET Dr. Ralph Snyderman, Chancellor Emeritus, Duke University, and Founder and Chairman of Proventys, Inc., Receives 2007 Leadership in Personalized Medicine Award   Nov 28, 07 08:00 ET Dey, L.P. Partners with COPD Foundation in Support of National Heart, Lung and Blood Institute (NHLBI)'s COPD Learn More Breathe Better Awareness Campaign   Nov 08, 07 13:49 ET Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference   13:36 ET Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference   Nov 07, 07 07:00 ET Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program   Nov 06, 07 06:00 ET Navigenics Launches With Preeminent Team of Advisers, Partners and Investors   Nov 02, 07 07:00 ET Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007   Oct 24, 07 16:01 ET Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD   16:01 ET Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD   16:00 ET Monogram Announces Third Quarter 2007 Financial Results   Oct 17, 07 17:15 ET Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call   Oct 16, 07 08:30 ET Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007   Oct 12, 07 17:31 ET FDA Approves Administration of LEXIVA(R) with Lower Dose of 'Boosting' Medication Ritonavir   Oct 10, 07 13:10 ET Monogram Biosciences to Present at the JMP Securities Healthcare Conference   Oct 08, 07 07:30 ET Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD   Oct 01, 07 07:00 ET Pfizer Receives E.U. Approval of Maraviroc; Monogram Initiates European Operations   Sep 27, 07 09:12 ET Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma   Sep 24, 07 07:00 ET Monogram Announces First Medicare Payment for Trofile(TM)   Sep 21, 07 08:00 ET Trial Date Set for Patent Infringement Suit Against Sepracor's Brovana(TM)   Sep 19, 07 07:00 ET Leading Policymakers, Scientists, Industry Executives Discuss Implementation of Evidence-Based, Personalized Medicine   07:00 ET Studies Highlight Superior Performance of Trofile(TM) Assay   Sep 18, 07 12:10 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay   08:30 ET Personalized, Online Help for Prescription Painkiller and Heroin Dependence: Confidential Treatment in a Doctor's Private Office   Sep 12, 07 12:12 ET Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults   11:10 ET Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month   10:38 ET Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide   Sep 07, 07 13:15 ET Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference   Sep 05, 07 07:00 ET Medicare Contractor Establishes Reimbursement Coding Guidance for Monogram's Trofile Assay   Aug 27, 07 14:06 ET Joint NJ/NY Rally for Addiction Recovery to be Hub of Events Nationwide   Aug 23, 07 07:00 ET Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007   Aug 13, 07 08:49 ET Introducing Addiction411: Online Tool to Educate the MySpace Generation about Opioid Addiction   Aug 10, 07 08:00 ET Introducing Addiction411: Online Tool to Educate the MySpace Generation About Opioid Addiction   Aug 06, 07 18:32 ET Monogram Biosciences Announces Conference Call to Discuss Commercial Introduction of Trofile(TM) Assay   13:05 ET Monogram Announces Commercial Introduction of Trofile(TM) Assay   Jul 26, 07 16:00 ET Monogram Announces Second Quarter 2007 Financial Results   Jul 25, 07 07:00 ET New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes   06:00 ET Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show   Jul 20, 07 18:07 ET Monogram Biosciences Announces Second Quarter 2007 Financial Results Conference Call   06:00 ET European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1   Jul 09, 07 01:15 ET Exelon(R)Patch, the First and Only Skin Patch for the Treatment of Alzheimer's Disease, Receives First Worldwide Approval in US   Jun 25, 07 07:00 ET Monogram Biosciences to Present at The C.E. Unterberg, Towbin Emerging Growth Opportunities Conference   Jun 23, 07 11:00 ET Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes   Jun 20, 07 18:00 ET Monogram Provides Update on Trofile(TM) Assay   Jun 18, 07 18:31 ET Medi-Cal Expands Coverage of Baseline HIV Resistance Testing   08:00 ET VeroScience Late-Breaking Abstract on Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions   Jun 04, 07 06:00 ET GlaxoSmithKline Launches Educational Campaign in Detroit to Address 'Silent Epidemic' of Genital Herpes Among African American Adults   May 31, 07 09:38 ET FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma   07:00 ET Monogram Presents Results of First eTag Breast Cancer Studies   May 30, 07 10:00 ET BioBank Central Launches Online Forum to Drive Global Connectivity Among Biobanking Community   May 21, 07 08:00 ET Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference   May 20, 07 13:45 ET Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference   May 17, 07 11:00 ET Neurotechnology Industry Report Says Revenues Grew 10% to $120.5 Billion in 2006; U.S. Economic Impact of Brain-related Illness Reached $1 Trillion   May 16, 07 16:35 ET Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2007   May 11, 07 14:25 ET FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD   May 07, 07 08:00 ET Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies   May 02, 07 16:00 ET Monogram Announces First Quarter 2007 Financial Results   Apr 26, 07 17:10 ET Monogram Announces Conference Call   Apr 25, 07 07:30 ET Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery   Apr 24, 07 20:24 ET FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1   14:27 ET Dey, L.P. Reaches Settlement with Commonwealth of Massachusetts on Pricing Litigation   Apr 17, 07 07:00 ET Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery   Mar 29, 07 14:01 ET Dey, L.P. Reaches Settlement with State of Nevada on Pricing Litigation   10:00 ET Neurotechnology Executives Tap Political Leaders to Help Patients With Brain- Related Illnesses   Mar 23, 07 13:24 ET Personalized Medicine Coalition Announces Support for Secretary Leavitt's Personalized Health Care Initiative   Mar 21, 07 17:12 ET Dey, L.P. Reaches Settlement with State of Hawaii on Pricing Litigation   Mar 15, 07 11:59 ET Message Carriers To Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'   Mar 13, 07 07:00 ET Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'   Mar 09, 07 05:00 ET U.S. Court of Appeals Reinstates Permanent Injunction Against Abbott Laboratories for Infringing Innogenetics' Patent   Mar 08, 07 10:29 ET Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'   Mar 07, 07 15:11 ET Hartford's HBO ADDICTION Premier draws recovery advocates, community leaders and people in recovery to support recovery from alcohol and other drug addiction   11:00 ET The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals   Mar 06, 07 10:11 ET The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals   Mar 05, 07 07:00 ET The Miami Coalition, The Hispanic Crime Prevention Program, Center for Administration of Justice, Florida International University and The F.I.U. Community-Based Intervention Research Group to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting   06:00 ET Scientific Data Highlights Pivotal Role of Monogram's Molecular Diagnostics in Development and Use of New HIV Treatments   Mar 02, 07 07:00 ET San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'   Mar 01, 07 15:06 ET Monogram Provides Update on Trofile(TM) Assay - Pfizer Reports Significant Reduction in Viral Load in Clinical Trial of Maraviroc   Feb 27, 07 09:43 ET San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'   Feb 13, 07 07:18 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay   Feb 08, 07 16:00 ET Monogram Announces Year-End 2006 Financial Results   Feb 05, 07 13:38 ET Monogram Biosciences Announces Fourth Quarter 2006 Financial Results Conference Call   Jan 17, 07 13:48 ET Personalized Medicine Coalition Supports President Bush's Call to Congress to Pass the Genetic Information Nondiscrimination Act   Jan 12, 07 07:00 ET Monogram Biosciences Prices Private Placement of Convertible Senior Unsecured Notes   Jan 11, 07 03:02 ET Court Permanently Halts Abbott's Sale of HCV Genotyping Products for Infringing Innogenetics' Patent   Jan 04, 07 12:43 ET Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs   03:22 ET Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit   Jan 02, 07 14:24 ET Monogram Biosciences To Present at the 25th Annual JPMorgan Healthcare Conference   Dec 29, 06 15:44 ET Levin Amendment Expands Access to 'Miracle Drug' to Treat Heroin Addiction   13:04 ET Bush Signs Law: More Patients May be Treated for Opioid Dependence/Addiction with Buprenorphine   Dec 11, 06 09:56 ET Congress Passes Legislation Increasing Treatment for Opioid Dependence/Addiction using Buprenorphine   Dec 08, 06 09:00 ET UCSF Pharmacy School Receives Major Grant From Amgen Foundation For Medicare Part D Outreach   Dec 01, 06 06:00 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay   Nov 28, 06 12:17 ET Dey, L.P. Reaches Settlement with State of Ohio on Pricing Litigation   10:12 ET Dr. Elizabeth G. Nabel, Director of the National Heart, Lung, and Blood Institute, Receives 2006 Leadership in Personalized Medicine Award   Nov 21, 06 06:00 ET Monogram Biosciences to Present at Personalized Medicine: A World of Opportunities   Nov 20, 06 06:00 ET Monogram Biosciences to Present at the Lazard Capital Markets Third Annual Life Sciences Conference   Nov 14, 06 15:47 ET Dey, L.P. Reaches Settlement with State of Idaho on Pricing Litigation   12:00 ET New Report Cites Emerging Impact of Personalized Medicine on Healthcare   Nov 13, 06 14:00 ET SyntheMed Announces Listing on Frankfurt Stock Exchange   Oct 30, 06 08:30 ET SyntheMed to Present at 8th Annual Rodman and Renshaw Healthcare Conference   Oct 26, 06 16:03 ET Monogram Announces Third Quarter 2006 Financial Results   Oct 23, 06 19:57 ET Monogram Biosciences Announces Third Quarter 2006 Financial Results Conference Call   08:30 ET SyntheMed to Present at the C.E. Unterberg, Towbin Life Sciences Conference   Oct 16, 06 20:36 ET Monogram Biosciences to Present at the BIO Investor Forum 2006   Oct 13, 06 08:30 ET SyntheMed Incorporated to Present at BIO InvestorForum 2006   Oct 12, 06 12:00 ET GlaxoSmithKline Sponsors HIV Medicine Association Minority Fellowship Program   Oct 03, 06 07:30 ET Detroit Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment   06:00 ET Monogram Announces $10 Million Revolving Line of Credit   Sep 28, 06 17:30 ET New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load   17:00 ET GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study   01:15 ET New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years   Sep 21, 06 08:30 ET Chicago Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment   Sep 19, 06 07:30 ET Available Medical Treatments Could Counter Growing Prescription Painkiller Abuse Among Young Adults, Teens   Sep 13, 06 17:00 ET Phase II Data Showing Clinical Benefits of Novel Once-Daily Oral Multiple Sclerosis Therapy FTY720 (Fingolimod) Published in New England Journal of Medicine   Sep 11, 06 13:15 ET Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice   07:30 ET SyntheMed Appoints John Benson as Controller   Sep 08, 06 22:14 ET Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent   Sep 07, 06 07:30 ET Nationwide Service to Match Opioid-Addicted Patients with Physicians Offering Private In-Office Medical Treatment   Sep 06, 06 07:00 ET SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)   Aug 31, 06 10:14 ET Alfacell Updates Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma   07:00 ET Midstate Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment   07:00 ET Philadelphia Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment   Aug 23, 06 08:48 ET SyntheMed Secures CE Mark Approval for REPEL-CV(R)   Aug 17, 06 17:00 ET Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay   12:45 ET Head-to-Head Study Comparing LEXIVA(R) (fosamprenavir calcium) to Kaletra(R) Presented at IAC 2006 and Published in The Lancet   Aug 14, 06 08:00 ET GlaxoSmithKline and Shionogi Complete Initial Clinical Study for HIV Integrase Inhibitor   Aug 13, 06 11:18 ET Updated HIV Treatment Guidelines Now Include Three GSK HIV Medications for Initial Antiretroviral Treatment Regimens   Aug 12, 06 08:00 ET Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay   Jul 25, 06 07:00 ET Monogram Announces Second Quarter 2006 Financial Results   06:00 ET Monogram Announces Allowance of U.S. Patent Related to eTag(TM) Technology   Jul 21, 06 13:34 ET Monogram Biosciences Announces Second Quarter 2006 Financial Results Conference Call   Jul 19, 06 10:00 ET Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment   Jul 05, 06 08:00 ET Monogram Biosciences to Present at the C. E. Unterberg, Towbin Emerging Growth Conference   Jun 27, 06 19:39 ET The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia   Jun 13, 06 08:30 ET Surging Heroin Addiction a Major Public Health Threat in Washington, D.C.   Jun 12, 06 08:00 ET Monogram Announces Settlement of CVR Liability   Jun 06, 06 08:00 ET Monogram Biosciences to Present at the Pacific Growth Equities' 2006 Life Sciences Growth Conference   May 31, 06 08:40 ET Opioid Addiction, a Major Public Health Threat in Atlanta, Often Overlooked and Untreated   08:38 ET Addiction to Prescription Painkillers and Heroin Surges in Pittsburgh, Most Widely Abused Drugs Citywide   May 26, 06 11:17 ET Monogram Announces Intention to Pay Any CVR Liability in Cash   May 24, 06 08:00 ET Monogram Announces Allowance of U.S. Patents for Its HIV Entry and Co-Receptor Tropism Technology   May 22, 06 08:00 ET Monogram Announces the Closing of Pfizer's $25 million Investment in Monogram   May 17, 06 17:24 ET FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease   May 08, 06 08:05 ET Monogram Announces First Quarter 2006 Financial Results   08:00 ET Pfizer to Invest $25 Million in Monogram   May 05, 06 18:14 ET Monogram Biosciences Announces First Quarter 2006 Financial Results Conference Call   Apr 26, 06 13:35 ET Monogram Biosciences to Present at the Deutsche Bank 31st Annual Health Care Conference   Apr 25, 06 16:27 ET Dey, L.P. Reaches Settlement with State of Missouri on Pricing Litigation   Mar 15, 06 12:19 ET TRACON Pharmaceuticals Assembles Industry-Leading Management Team to Support Development of Targeted Cancer Therapy Pipeline   Feb 28, 06 19:14 ET Monogram Biosciences to Present at the SG Cowen & Co. 26th Annual Health Care Conference   Feb 22, 06 08:03 ET Monogram Announces Year End 2005 Financial Results   Feb 21, 06 11:17 ET Monogram and Merck to Collaborate on Phase III Trials of Merck's Investigational HIV-1 Integrase Inhibitor   Feb 15, 06 18:30 ET Monogram Biosciences Announces Fourth Quarter 2005 Financial Results Conference Call   07:01 ET Monogram and Dana-Farber Cancer Institute Enter Collaboration Agreement   Feb 14, 06 08:07 ET Dey, L.P. Names Christy Taylor New SVP for Sales, Marketing and Business Development   Feb 09, 06 13:00 ET Data Highlighting the Role of Molecular Diagnostics Presented at Major HIV/AIDS Meeting   Feb 01, 06 07:03 ET National Survey Finds Nearly Half of Public Unaware Prescription Painkiller Abuse is as Harmful as Using Heroin   Jan 12, 06 08:00 ET More Than 900 Hospitals Sign with U.S. Surgical Under Novation Supply Agreements   Jan 05, 06 02:30 ET Merck KGaA Names Engle New Generics Group Regional Director, North America      Jan 04, 06 16:53 ET Monogram Biosciences to Present at the 24th Annual JPMorgan Healthcare Conference   Dec 15, 05 07:01 ET Monogram Presents Data Demonstrating Cost-Effectiveness of PhenoSense GT(TM) and Leadership in Advancing HIV Resistance Testing   Dec 01, 05 07:01 ET Monogram's eTag(TM) Technology Featured in British Journal of Cancer   Nov 30, 05 10:08 ET Number of Pills Affects Adherence to HIV Treatment Regimens   Nov 18, 05 09:46 ET FDA Approves Updated Labeling for GSK's LEXIVA   Nov 16, 05 11:49 ET World COPD Day: 12 Million Americans Unaware They Are at Risk for Fourth Leading Cause of Death   Nov 04, 05 08:49 ET Icagen Reports Third Quarter 2005 Financial Results   Nov 03, 05 08:09 ET Dr. Janet Woodcock of U.S. Food and Drug Administration to be Presented with First Leadership in Personalized Medicine Award   08:09 ET New Survey Shows Americans Want Genetic Information in Health Care, But Fear Privacy, Ethical, Emotional Implications   Nov 01, 05 17:54 ET Icagen to Present at Two Upcoming Conferences   Oct 27, 05 09:02 ET Icagen Announces Third Quarter 2005 Financial Results Conference Call   Sep 19, 05 09:00 ET Icagen to Present at the 2005 UBS Global Life Sciences Conference   Aug 04, 05 09:07 ET New Study Suggests Patients With Schizophrenia Improved With Treatment Change to RISPERDAL(R) CONSTA(R)   Aug 03, 05 12:44 ET President Bush Signs Bill Lifting Restriction on Office-Based Treatment with Buprenorphine for Opioid Dependence/Addiction   Jul 27, 05 14:56 ET Congress Passes Legislation to Lift Restriction on Medical Groups that Prescribe Buprenorphine for Opioid Dependence/Addiction   11:00 ET Patient Satisfaction With Once-Daily Dosing Of HIV Fixed-Dose Combination Tablet EPZICOM   Jul 26, 05 11:00 ET Epidemiology Study Reports New Information on Hypersensitivity Reactions to Abacavir   11:00 ET Long-Term Safety Data Of LEXIVA/R In HIV Patients Co-Infected With Hepatitis   Jun 16, 05 12:11 ET Many Patients With Schizophrenia Who Transitioned to RISPERDAL(R) CONSTA(R) Avoided Relapse and Experienced Symptom Improvement   Jun 07, 05 17:12 ET MedQuist Eliminates Use of AAMT Line Unit of Measure   May 27, 05 07:00 ET FDA Grants Approval to Market Focalin XR(TM) for the Treatment of ADHD in Adults, Adolescents and Children   Apr 28, 05 14:43 ET DEY, L.P. Donates Time and Resources to Brighten Seneca Center   Apr 26, 05 09:17 ET Neve Campbell Helps Launch National Program for People Living with Epilepsy   Apr 11, 05 09:12 ET Mass. Biotechnology Council and MassBioEd Announce $9M Major Public/Private Partnership to Advance Science Education in the State   Apr 08, 05 08:01 ET Sen. Kennedy, State Legislative Leaders, Mass Biotechnology Council and MassBioEd to Launch Major High School Science Education Initiative with an Event at the Statehouse   Apr 01, 05 09:08 ET Genzyme Corporation Becomes First Corporate Sponsor of BioTeach Program ------------------------------------------------ Makes five-year, $250,000 commitment   Mar 30, 05 07:05 ET Ardais(R) and Cytomyx Announce Translational Medicine Collaboration   Mar 22, 05 10:47 ET Personalized Medicine Coalition Supports FDA's Pharmacogenomic Data Submissions Guidance   Feb 25, 05 09:00 ET Ardais(R) and ATCC to Deliver Scaleable Biospecimen Management Solution for Translational Medicine   Feb 18, 05 08:16 ET Cyclacel & U. of Edinburgh Scientists Solve 3-D Structures of PCNA Complexes: Important Target for New Cancer Treatments   08:00 ET US Patent Granted to Cyclacel for Novel Cyclin Dependent Kinase Inhibitor Series   Feb 01, 05 08:17 ET University of Arkansas for Medical Sciences Adopts Ardais(R) Biospecimen Management System   Jan 26, 05 10:21 ET Stephen Elledge, Ph.D., of Harvard/Partners Center for Genetics and Genomics Receives Premier Award from Genetics Society of America   Jan 14, 05 12:39 ET Icagen and Abbott Renew Drug Discovery Collaboration   08:01 ET Napa Chamber of Commerce Names DEY, L.P. Business of the Year   Jan 12, 05 09:01 ET Scandius BioMedical's Stratis (TM) ST ACL Reconstruction System launched and successfully used in initial surgeries   Jan 03, 05 17:18 ET DEY, L.P. Donates $100,000 to the American Red Cross Tsunami Disaster Relief Effort   Dec 09, 04 07:01 ET New Study in the New England Journal of Medicine Shows Exelon May Help Parkinson's Disease Patients Who Suffer From Dementia   Dec 06, 04 17:47 ET Icagen Reports Positive Results of Phase II Clinical Trial of ICA-17043 for The Treatment of Sickle Cell Anemia   08:33 ET Bristol-Myers Squibb Launches ChoiceDM(TM) A1C Home Test -- First At-Home Test to Measure Long Term Blood Sugar Control   Nov 22, 04 09:00 ET Transport Pharmaceuticals Secures $27 Million in Venture Financing to Continue Development of Unique Drug Delivery Platform   Nov 19, 04 08:01 ET Chest Symposium Offers Guidance on COPD Best Clinical Practices for Inhalation Therapy, Dangers of Pharmacy Compounded Respiratory Products   Nov 16, 04 08:00 ET Dey, L.P. to Fund 2005 Nationwide COPD Patient Education Days Through National Emphysema/COPD Association (NECA)   Nov 09, 04 16:12 ET Novartis Institutes for BioMedical Research Unveils Redesigned Water Tower and Announces Educational Collaborations      Nov 08, 04 09:11 ET Science Selects Cyclacel Work as Editor's Choice   09:09 ET Beneficial Effects of Seliciclib (CYC202) Reported in Models of Kidney Disease   09:06 ET FDA Grants Scandius BioMedical Market Clearance for Novel Technology Designed to Simplify Common Sports-Related Surgery   08:07 ET Dey, L.P. Reaches Settlement with State of Arkansas on Pricing Litigation   Oct 27, 04 17:00 ET Novartis and the Broad Institute of MIT and Harvard Announce Unique Public/Private Collaboration to Uncover Genetic Basis for Type 2 Diabetes   Oct 26, 04 16:45 ET Novartis and Orion Pharma Launch First Parkinson's Disease Study to Explore Potential of Delaying Motor Complications with Stalevo (R)   Oct 25, 04 08:06 ET New Studies Suggest Investigational Once-Daily ADHD Treatment Is Safe and Effective in Both Children and Adults   Oct 21, 04 09:03 ET New Coalition Launched to Advance Personalized Medicine   Sep 02, 04 09:01 ET Icagen Receives Milestone Payment from McNeil Consumer & Specialty Pharmaceuticals   Aug 24, 04 14:05 ET Maine Medical Center Adopts Ardais(R) Biospecimen Management System   Aug 12, 04 07:02 ET Ardais(R) Corporation Raises Additional $4 Million to Reach Cash Flow Breakeven   Aug 02, 04 09:06 ET Vital Therapies, Inc. Receives Orphan Drug Designation for Key Component in Liver Assist Program   Jul 26, 04 07:03 ET Cyclacel Announces Postponement of Initial Public Offering   Jul 15, 04 09:01 ET BioTrove, Inc. Licenses Genomics Application from Stanford University for Nanotiter Plates   Jul 07, 04 09:31 ET New Office-Based Treatment for Prescription Drug and Heroin Addiction   Jul 02, 04 07:21 ET Cyclacel Announces Registration for Initial Public Offering   Jun 29, 04 09:00 ET Icagen and McNeil Consumer & Specialty Pharmaceuticals Enter into Development And Commercialization Agreement for Sickle Cell Disease Treatment   Jun 16, 04 08:32 ET Icagen Expands Senior Management Team   Jun 14, 04 09:01 ET Spherics, Inc. Begins Phase I Clinical Trial with Spherazole(TM), Bioadhesive-Based Itraconazole   Jun 07, 04 09:10 ET Spherics, Inc. Appoints Avinash Nangia, Ph.D. as Vice President of Research and Development   09:06 ET Researchers Present Results from Studies of Therion's Therapeutic Cancer Vaccines in Patients with Pancreatic Cancer   Jun 03, 04 09:03 ET BioTrove, Inc. Appoints Alan Barber as Chief Financial Officer   Jun 02, 04 08:33 ET RISPERDAL (R) (risperidone) Shown to Rapidly Reduce Manic Symptoms Associated With Bipolar I Disorder   May 25, 04 08:05 ET NECA's COPD Patient Needs Assessment Survey Presented at American Thoracic Society   May 24, 04 08:32 ET Therion Biologics Corporation Receives FDA Agreement to Initiate Phase III Clinical Trial With PANVAC(TM)-VF In Advanced Pancreatic Cancer   08:18 ET Scientists From Australia and New Zealand Discuss Stem Cell Research and Clinical Trials at 3rd Annual Conference in Cambridge, Massachusetts   May 19, 04 11:01 ET MorphoSys and Novartis Forge Strategic Antibody Alliance   May 12, 04 09:00 ET Novartis Teams Up with Parkinson's Disease Groups to Launch New Resource for the 1.5 Million People Living with Parkinson's Disease   May 06, 04 09:01 ET BioTrove, Inc. Appoints Michael Olex as Vice President of Manufacturing   May 05, 04 12:01 ET RISPERDAL(R) CONSTA(TM) IMPROVES SYMPTOM CONTROL IN MANY PEOPLE WITH SCHIZOPHRENIA   12:00 ET MANY STABILIZED, YOUNG ADULTS WITH SCHIZOPHRENIA MAY BENEFIT FROM EARLY TREATMENT WITH RISPERDAL(R) CONSTA(TM)   07:31 ET New Study Suggests Investigational ADHD Treatment is Safe and Effective in Adults   May 03, 04 09:04 ET 'Jubiloso/Lamentoso: An Evening of Great Music from Composers who Lived with Bipolar Disorder' Raises Awareness of a Serious Mental Illness   Apr 26, 04 09:05 ET BioTrove, Inc. Appoints Alan Carter as Vice President of Worldwide Sales   Apr 19, 04 08:08 ET Dynogen Secures $50 Million Series B Financing to Advance Its Pipeline Of Genitourinary and Gastrointestinal Development Programs   08:07 ET Duke University Medical Center and Ardais Launch Biorepository for Clinical Research in Cancer   Apr 15, 04 09:11 ET BioTrove, Inc. Completed a $13.7 Million Round of Financing With the Closing of a Second Traunch of $2.8 Million   Apr 14, 04 08:08 ET U.S. Genomics Licenses Locked Nucleic Acid (LNA (TM)) Chemistries from Exiqon   Apr 06, 04 08:05 ET Ardais Announces Expansion of Aventis Collaboration to Support Target Validation Efforts   Mar 25, 04 09:01 ET BioTrove Launches SNP Genotyping Capability -- The First Application of the Living Chip(TM) Nano-Fluidics Technology Platform   Mar 22, 04 09:22 ET BioTrove's Momentum Signs First Contract with Large Pharmaceutical Customer   Mar 11, 04 08:34 ET VaxInnate Corporation Raises $23.1 Million in Series B Financing   Mar 10, 04 10:59 ET Feinstein Kean Healthcare Program Wins Paul G. Rogers/NCPIE Medication Communicator Award   08:32 ET Scion Pharmaceuticals Announces Appointment of Valentin Gribkoff, Ph.D., as Vice President of Biology   Mar 09, 04 11:12 ET Scion Pharmaceuticals to Present at SG Cowen Health Care Conference   Feb 19, 04 08:01 ET Novartis Institutes for BioMedical Research Selects Feinstein Kean Healthcare as Agency of Record   Feb 02, 04 11:43 ET Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery And Development Programs   08:30 ET Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery and Development Programs   Dec 23, 03 16:01 ET Icagen Initiating Phase I Clinical Development Program for ICA-69673, a Novel Drug Candidate for Epilepsy   Dec 22, 03 08:31 ET Dynogen Pharmaceuticals, Inc. Enters into Agreement with Mitsubishi Pharma for Irritable Bowel Syndrome Compound   Dec 10, 03 08:10 ET Study Suggests RISPERDAL(R) CONSTA(TM), New Treatment For Schizophrenia, May Further Relieve Symptoms of Stable Patients   Dec 09, 03 08:00 ET Treating Schizophrenia Patients With RISPERDAL(R) CONSTA(R) May Reduce Hospitalization Rates And Cost Of Care   Dec 05, 03 08:00 ET FDA Approves Risperdal (R) for Treatment of Bipolar Mania   Dec 03, 03 15:58 ET Risperdal (R) Consta (R), First and Only Long-Acting, Newer-Generation Schizophrenia Treatment, Now Available   Nov 20, 03 14:01 ET Scientists Report on Promising New Approaches to Induce Cancer Cell Suicide   10:15 ET Three Molecular-Targeted Compounds Show Promise Against Cancers in Early Clinical Studies   08:30 ET Icagen and Abbott Laboratories Renew Drug Discovery Collaboration   Nov 19, 03 10:50 ET Scientists Discover Potential Approaches to Enhance Existing Cancer Therapies   10:49 ET Proteins May Help Identify Patients Who Will Respond Better to Different Treatments in Certain Cancers   10:47 ET New Drug Target and Biomarker for Advanced Childhood Cancer Discovered; Advances with Two Kinase Targets Reported   10:01 ET New Drug Target and Biomarker for Advanced Childhood Brain Cancer Discovered; Advances with Two Kinase Targets Reported   Nov 18, 03 12:47 ET Circadian Clock Genes May Provide Targets for New Cancer Drugs   Nov 13, 03 08:31 ET Nephros Therapeutics Appoints Richard Stead, MD as Chief Medical Officer and Karen Brennan as Senior Director of Clinical Operations   Nov 12, 03 11:27 ET Feinstein Kean Healthcare Expands Pharmaceutical and Consumer Health Practice Leadership   Nov 05, 03 09:30 ET Feinstein Kean Healthcare Wins Two 2003 Mature Media Awards   Nov 04, 03 09:45 ET Interim Results of Alzhemed(TM) Open-Label Phase II Extension Study Demonstrates Cognitive Benefits in Patients With Alzheimer's Disease   Oct 30, 03 08:05 ET FDA Approves RISPERDAL(R) CONSTA(TM) For Treating Schizophrenia   Oct 29, 03 19:10 ET FDA Approves RISPERDAL(R) CONSTA(TM) for Treating Schizophrenia   Sep 17, 03 08:32 ET Now Available, New Stalevo Addresses Top Parkinson's Disease Concern   Sep 10, 03 09:15 ET Feinstein Kean Healthcare Expands Pharmaceutical Communications Practice   08:31 ET Scion Announces Appointment of Ray Winquist, Ph.D., F.A.H.A., as Vice President of Pharmacology   Sep 09, 03 08:25 ET ArQule Completes Acquisition Of Cyclis Pharmaceuticals, An Ampersand Ventures' Portfolio Company   Sep 03, 03 08:03 ET Icagen Completes Patient Enrollment For Phase II Sickle Cell Anemia Clinical Trial   Aug 26, 03 09:15 ET First of its Kind Study Aims to Answer Important Questions About Girls and ADHD   Aug 22, 03 09:02 ET Data Show Exelon(R) Reduces Behavioral Disturbances Associated with Alzheimer's Disease   Aug 11, 03 08:06 ET BioTrove, Inc. Launches Momentum(TM) Technology - Ultra High-Throughput Mass Spectrometry System - For Functional Assay Development   Aug 07, 03 15:24 ET Trileptal(R) (oxcarbazepine) is Approved for Use as Monotherapy in Children With Epilepsy   Aug 01, 03 08:31 ET Jennifer Viera Joins Feinstein Kean Healthcare as Account Director   Jul 02, 03 15:05 ET Neurochem Clinical Advisory Board Recommends Initiation of Phase III For Alzhemed(TM)   09:04 ET Georges Haas, Ph.D. Joins Scion Pharmaceuticals' Board of Directors   Jun 23, 03 09:02 ET Neurochem Conference Call and Web Cast on Alzhemed(TM) Phase II Study for Alzheimer's Disease at 10:00 A.M. Et Today   08:25 ET Neurochem Reports Promising Findings From Alzhemed(TM) Phase II Study For Alzheimer's Disease      Jun 19, 03 09:00 ET Cyclis Provides Update on Research Programs and Business Activities at BIO 2003   Jun 13, 03 08:30 ET FDA Approves Stalevo (TM) for Treatment of Parkinson's Disease   Jun 11, 03 07:01 ET Renal Amyloidosis Worsens Familial Mediterranean Fever prognosis   Jun 02, 03 09:14 ET Study Published in Psychiatric Journal Supports Efficacy of First Long-Acting, Newer-Generation Schizophrenia Treatment   May 30, 03 14:30 ET Neurochem to Present at The Annual UBS Warburg Global Specialty Pharmaceuticals Conference   08:01 ET BioTrove Names Robert H. Ellis as Chief Operating Officer   May 19, 03 18:02 ET Walk a Mile in Their Shoes: Psychiatrists Get Firsthand Look at Coping with Schizophrenia   May 14, 03 08:33 ET Spherics, Inc. Appoints Ze'ev Shaked, Ph.D., as Chief Executive Officer and Director   08:09 ET Xantos Biomedicine Accesses the Ardais BIGR(TM) Library for Clinical Validation of its Targets in Inflammatory and Degenerative Diseases   May 07, 03 17:01 ET Neurochem Licenses its Diabetes Technology to Innodia Inc.   08:01 ET U.S. Genomics Secures $25 Million in Equity Financing   May 06, 03 09:39 ET New, More Convenient Form of Leading Schizophrenia Medication Risperdal (R) Now Available   May 05, 03 05:45 ET BioMarin Announces First Quarter 2003 Financial Results   May 02, 03 11:07 ET Data Show Schizophrenia Patients who Miss Just a Few Days of Medication are at Increased Risk for Hospitalization   Apr 24, 03 10:07 ET ALS Therapy Development Foundation Appoints Clinical Advisory Board   Apr 22, 03 10:30 ET ALS Therapy Development Foundation to Present at Massachusetts Biotechnology Council Annual Meeting   Apr 15, 03 10:03 ET Zapaq Inc. Announces Fundamental U.S. Patent on Tools for Discovering Memapsin 2 (beta-secretase) Inhibitors to Treat Alzheimer's Disease   Apr 10, 03 13:32 ET Francesca DeVellis Returns to Feinstein Kean Healthcare as Vice President, Biotechnology Communications   11:02 ET Neurochem's Data Safety Monitoring Board Recommends Continuation of Pivotal Phase II/III Clinical Trial for Fibrillex(TM)   Apr 01, 03 08:01 ET BioTrove, Inc. Relocates Corporate Headquarters to Woburn, Massachusetts   Mar 26, 03 08:03 ET U.S. Genomics Names Stephen P. DeFalco, Former PerkinElmer Executive, as New Chief Executive Officer and Chairman   01:30 ET Majority Interest in Idenix Pharmaceuticals, an MPM Capital Portfolio Company, to be Acquired by Novartis Pharma AG   Mar 12, 03 08:32 ET Peptimmune, Inc. Secures $41.2 Million in Venture Capital Financing   Mar 03, 03 09:04 ET Cyclis to Present at Life Science Ventures Conference   Feb 24, 03 08:31 ET Nephros Therapeutics Announces Senior Executive Appointments   Feb 18, 03 09:03 ET Cyclis Pharmaceuticals Reports Studies Defining New Mechanism for Potential Cancer Therapies   08:05 ET BioStratum and DakoCytomation Announce License Agreement for Cancer Diagnostic Antibody   Feb 12, 03 06:00 ET Altus(R) and Dr. Falk Pharma Announce Alliance to Develop and Market TheraCLEC(TM) in Europe   Feb 09, 03 13:00 ET BioMarin Announces Fourth Quarter and Year-end 2002 Financial Results   Feb 05, 03 16:21 ET BioMarin Announces Public Offering of 6,000,000 Shares of Common Stock   Jan 30, 03 10:30 ET Evotec OAI to Support Dynogen Pharmaceuticals in the Discovery and Development of Novel Pharmaceuticals   09:08 ET Neurochem Lead Investigator Awarded NIH Grant to Support U.S. Phase II Clinical Trials of Cerebril(TM)   Jan 27, 03 09:05 ET Neurochem to Present at the Annual U.S. Bancorp Piper Jaffray Healthcare Conference   Jan 07, 03 13:00 ET Neurochem to Present at The 21st Annual JP Morgan H&Q Healthcare Conference   Jan 06, 03 08:30 ET Neurochem Appoints Dr. Philippe Calais as New President   Dec 23, 02 08:30 ET ZymoGenetics and Amgen Settle Patent Infringement Lawsuit for the Rheumatoid Arthritis Drug Enbrel(R) (etanercept)   Dec 20, 02 17:05 ET BioMarin Files Shelf Registration Statement   09:00 ET Icagen and Bristol-Myers Squibb Renew Drug Discovery And Development Collaboration   Dec 19, 02 18:33 ET Therion Biologics and the National Institute of Allergy and Infectious Diseases, NIH, Initiate Human Clinical Trials of Preventive Smallpox Vaccine   Dec 03, 02 17:06 ET ZymoGenetics Highlights Development Programs at Analyst & Investor Briefing   Nov 21, 02 16:00 ET ZymoGenetics to Hold Analyst & Investor Briefing In New York City on December 3rd   Nov 11, 02 10:00 ET BioStratum Incorporated to Present at BIO-Europe 2002 and BIO-Scandinavia 2002   Nov 07, 02 16:15 ET ZymoGenetics Reports Third Quarter 2002 Financial Results   09:00 ET Dey L.P. Provides $25,000 Grant to National Emphysema/COPD Association   Nov 06, 02 09:03 ET BioTrove Raises $5.25 Million in Venture Financing   Nov 05, 02 08:00 ET Neurochem Presents Further Scientific Evidence of Disease Modifying Activity With its Drug Candidate for the Treatment of Alzheimer's Disease and Cerebral Amyloid Angiopathy   Nov 04, 02 10:39 ET BioStratum Incorporated Presents at the American Society of Nephrology's 35th Annual Meeting and Scientific Exposition   Oct 31, 02 00:30 ET BioMarin Announces Third Quarter 2002 Financial Results   Oct 29, 02 10:02 ET Neurochem Announces Webcast of Presentation at the 4th Annual Mass Opportunities Investor Conference   Oct 28, 02 06:30 ET IBEX Technologies Announces Potential New Diagnostic Test To Predict The Progression Of Osteoarthritis   06:30 ET IBEX Technologies Announces The Discovery of a Novel Arthritis Target   Oct 25, 02 09:14 ET Investigational New Drug In The U.S. For Cerebril(TM) Takes Effect And Signals Initiation Of Phase II Clinical Trial   08:32 ET Cyclis to Present at MASS Opportunities Investment Conference   Oct 22, 02 10:57 ET U.S. Genomics Awarded Patent for DNA Analysis Methods   Oct 16, 02 08:29 ET Cyclis to Present at the VentureWire Lifescience Portfolio Conference   Oct 09, 02 08:28 ET Cyclis Completes Licensing Agreement with Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute   08:04 ET ZymoGenetics Adds Interleukin-21 (IL-21) to Its Product Development Pipeline   Oct 07, 02 09:01 ET Icagen Announces Fast Track Status for ICA-17043 - A Novel Treatment for Sickle Cell Anemia   08:30 ET ZymoGenetics, Inc. and Alexandria Real Estate Equities, Inc. Complete $52 Million Sale Leaseback Transaction   Oct 02, 02 10:00 ET BioStratum Announces Strategic Management Changes and Appointments   Sep 30, 02 10:04 ET Neurochem Announces Positive Developments for its Alzheimer's Disease Program   08:32 ET Barrier Therapeutics Appoints Anne VanLent as Executive Vice President and Chief Financial Officer   00:30 ET BioMarin Proceeds With Neutralase (TM) Phase III Clinical Trial   Sep 25, 02 10:01 ET BioStratum Announces Agreements with Genzyme for Alport Syndrome Technology and Research   Sep 23, 02 17:54 ET Icagen Presents Results of Phase Ib Clinical Trial for ICA-17043 -- A Novel Treatment for Sickle Cell Disease   Sep 18, 02 08:30 ET Nephros Therapeutics Completes $17 Million Financing to Accelerate Clinical Development of Proprietary RAD System to Treat Acute Renal Failure   Sep 17, 02 08:32 ET ZymoGenetics Files Investigational New Drug Application For Recombinant Human Factor XIII To Treat Congenital Deficiency   08:30 ET Therion Biologics Licenses ICAM-1 from Boehringer Ingelheim   Sep 12, 02 00:30 ET BioMarin Adopts Stockholder Rights Plan   Sep 09, 02 08:30 ET Therion Biologics Corporation Strengthens Management Team   Sep 04, 02 08:47 ET U.S. Genomics Awarded $499,500 DARPA Contract to Examine Applicability Of Genomic Mapping Technology   08:31 ET Cyclis Receives Notice of Allowance for Key U.S. Patent Relating to CO-501   Sep 03, 02 10:04 ET BioStratum Incorporated Presents at the European Association for the Study of Diabetes Annual Meeting   Aug 29, 02 10:37 ET Neurochem Files Investigational New Drug Application For Alzhemed(TM) to Treat Alzheimer's Disease   Aug 27, 02 08:33 ET Spherics, Inc. Appoints Mathias Woker to VP, Business Development; Mark Iampietro to Director of Quality Assurance; and Daniel Magiera to Principal Scientist in Analytical Chemistry   Aug 22, 02 00:30 ET BioMarin Completes Acquisition of Glyko Biomedical Ltd.   Aug 19, 02 08:30 ET Barrier Therapeutics Appoints Charles Nomides as New Chief Operating Officer   Aug 15, 02 08:01 ET J. Craig Venter, Ph.D., Joins the Board of Directors at U.S. Genomics   Aug 14, 02 08:32 ET Spherics, Inc. Raises $10 Million in Series B Financing   Aug 08, 02 08:30 ET ZymoGenetics Reports Second Quarter 2002 Financial Results   Aug 06, 02 15:28 ET Chickenpox Vaccination Now Required for Kindergarten, 1st Grade and 7th Grade Enrollment in Pennsylvania   15:28 ET Chickenpox Vaccination Now Required for School Enrollment in Michigan   Aug 01, 02 02:00 ET OGS Announces Board Change   00:30 ET BioMarin Announces Second Quarter 2002 Financial Results   Jul 31, 02 00:30 ET BioMarin Receives U.S. Patent Covering Aldurazyme(TM) for Treatment of MPS I   Jul 30, 02 08:01 ET Cyclis to Present at IBC Drug Discovery Technology 2002 Conference   04:00 ET Roche Licenses Compounds to Treat Alzheimer's Disease from Memory Pharmaceuticals   Jul 29, 02 08:31 ET ZymoGenetics Announces License Agreement for Interleukin-13 Receptor With Wyeth   Jul 26, 02 02:00 ET OGS Announces Positive CPMP Opinion for Zavesca(TM)* for Type 1 Gaucher Disease in European Union   02:00 ET OGS and Actelion Announce Marketing and Distribution Partnership For Zavesca(TM)* in Europe   Jul 24, 02 02:00 ET OGS Announces Decision by Ethics Committee in Israel to End Temporary Suspension of Vevesca (OGT 918) Trials   Jul 23, 02 09:15 ET Parents' Misperceptions about Chickenpox May Influence Vaccine Decisions   08:33 ET Neurochem Scientists Report On Multiple Research And Therapeutic Programs For Alzheimer's Disease   Jul 22, 02 10:06 ET FDA Grants BioStratum Fast Track Status for Company's Lead Drug Candidate, Pyridorin (TM)   Jul 18, 02 12:06 ET ZymoGenetics Receives U.S. Patent on ADAM33 Protein   Jul 17, 02 07:59 ET Cyclis Pharmaceuticals Completes $5 Million Initial Financing to Develop Small Molecule Cancer Drugs Based on Activated Checkpoint Therapy   Jul 15, 02 00:30 ET BioMarin Appoints New CFO and Three New Board Members   Jul 12, 02 02:00 ET OGS and Cystic Fibrosis Foundation Therapeutics Inc. Launch a Major Proteomics Initiative to Advance Management of Cystic Fibrosis   Jul 08, 02 00:30 ET BioMarin Creates Science Advisory Board   Jul 05, 02 00:30 ET BioMarin Schedules Annual Meeting for August 13, 2002   Jun 25, 02 00:30 ET BioMarin Announces Positive Findings from Phase 1 Trial and Extension Study of Aryplase(TM) for MPS VI   Jun 24, 02 08:32 ET ZymoGenetics Announces Novo Nordisk A/S Has Converted Its Non-Voting Shares of ZymoGenetics Stock into Voting Shares   02:00 ET OGS Receives Complete Response Letter from the FDA on Vevesca (OGT 918)   Jun 17, 02 10:00 ET BioStratum Incorporated Presents at the American Diabetes Association's 62nd Scientific Sessions Meeting   Jun 15, 02 13:00 ET New Study Suggests that Weight Loss with Xenical(R) (orlistat) Improves Glycemic Control in Type 2 Diabetes Patients Taking Maximal Doses of Anti-Diabetic Medications   13:00 ET Three Studies Presented at American Diabetes Association Meeting Suggest Weight Loss with Xenical(R) (orlistat) Provides Additional Benefits for Type 2 Diabetes Patients When Combined with Current Therapies   Jun 14, 02 00:30 ET BioMarin Announces Upcoming Clinical Trial Data Presentations Regarding Aldurazyme(TM) for MPS I and Aryplase(TM) for MPS VI   Jun 13, 02 08:31 ET Coley Pharmaceutical Group Initiates Phase I/II Clinical Trial of CpG 7909 in Melanoma Patients   Jun 10, 02 07:31 ET ZymoGenetics and Regeneron Sign License Agreement for Ig-Fusion Protein Technology   Jun 06, 02 10:48 ET Memory Pharmaceuticals to Present at Bio 2002 in Toronto June 9-12, 2002   Jun 03, 02 08:31 ET ZymoGenetics Provides Update on Manufacturing Plans   May 29, 02 08:30 ET BioMimetic Pharmaceuticals Initiates Pivotal Clinical Study with Platelet-derived Growth Factor for the Treatment of Periodontal Diseases   May 24, 02 12:48 ET OGS Appoints New Chief Executive Officer   May 23, 02 08:29 ET ZymoGenetics and Arriva Pharmaceuticals Sign Agreement for Alpha 1-Antitrypsin -US patent covers commercial production of AAT in yeast-   May 19, 02 19:12 ET Columbia/ECOG Researchers Stabilize PSA Levels and Clinical Progression in Prostate Cancer Patients Following Treatment with Therapeutic Vaccines   May 15, 02 08:32 ET Point Reports First Quarter 2002 Financial Results   00:30 ET BioMarin Provides Update on NeuroTrans(TM) Brain Delivery Program   May 10, 02 16:22 ET Barrier Therapeutics Raises $46 Million in Private Financing   May 08, 02 08:33 ET ZymoGenetics Reports First Quarter 2002 Financial Results - Completion of IPO Highlights Quarter -   May 07, 02 00:30 ET BioMarin Announces First Quarter 2002 Financial Results   May 02, 02 09:56 ET Oxford GlycoSciences Plc Monotherapy study 001 results on Vevesca (OGT 918) presented at EWGGD   09:56 ET Oxford GlycoSciences Plc Switch/Combination Study 004 Results on Vevesca (OGT 918) Presented at EWGGD   Apr 29, 02 10:10 ET BioStratum Raises $20 Million in Private Financing; Makes Strategic Acquisition of BioCrine AB   08:30 ET ZymoGenetics Reports New Preclinical Findings on Zfgf5, a Novel Growth Factor Implicated in Cartilage Repair   Apr 24, 02 09:53 ET OGS Temporarily Halts Vevesca (OGT 918) Treatment in Israel as a Precaution Pending Investigation of an Unexplained Adverse Event   Apr 22, 02 00:30 ET BioMarin Initiates Phase 2 Trial of Aryplase (TM) Enzyme Replacement Therapy for MPS VI   Apr 19, 02 10:01 ET Karl Tryggvason, M.D., Ph.D. Awarded 2002 Louis-Jeantet Prize for Medicine   Apr 11, 02 08:31 ET Coley Pharmaceutical Group Strengthens Management Team and Expands Board of Directors   Apr 10, 02 15:17 ET New Study Shows Restrictions Hurt Medicaid Patients   Apr 04, 02 08:50 ET Neurochem Presents Phase I Clinical Trials Results and Proof-of-Concept Data for Drug Candidate Alzhemed (TM) for Alzheimer's Disease   Apr 03, 02 08:29 ET Therion Biologics Adds to Board of Directors   Mar 29, 02 09:01 ET Abbott Laboratories and Icagen Expand Drug Discovery Collaboration   Mar 27, 02 08:31 ET Therion Names Mark Leuchtenberger, Former Vice President of Biogen International, as President and CEO   Mar 25, 02 08:59 ET Memory Pharmaceuticals Completes $40 Million Private Financing to Accelerate Neurological Drug Discovery and Development   Mar 21, 02 02:02 ET Oxford GlycoSciences Plc Preliminary Audited Results For the Year Ended 31 December 2001   02:00 ET Oxford GlycoSciences Plc Update on Vevesca (OGT 918)   Mar 18, 02 08:19 ET U.S. Genomics Awarded Pioneering Patent for Direct, Linear Analysis of DNA   Mar 15, 02 16:30 ET HMSR, Inc. Completes Merger with Point Therapeutics, Inc.   Mar 14, 02 02:00 ET OGS and BioInvent form Therapeutic Antibodies Alliance   Mar 13, 02 08:29 ET BTG and ISREC Release New Data Supporting Use of Adenoviral Treatment For Colorectal Cancer   Mar 11, 02 08:31 ET ZymoGenetics Reports Fourth Quarter and Year End 2001 Financial Results   08:29 ET James E. Barrett, Ph.D. Named Senior Vice President, Research and Development of Memory Pharmaceuticals   Mar 07, 02 16:38 ET ZymoGenetics Files Patent Infringement Suit Against Immunex   02:10 ET 2002 R&D UPDATE   02:00 ET OGS CEO to Step Down by Year-End   Mar 05, 02 11:30 ET OGS Appoints Donald W. DeGolyer to Main Board as President of Global Therapeutics   Feb 28, 02 16:15 ET High School Students Experience a Day in the Life of Feinstein Kean Healthcare   Feb 27, 02 10:16 ET BioStratum Incorporated to Present at BioSquare 2002   Feb 25, 02 00:30 ET BioMarin Announces Fourth Quarter and Year-end 2001 Financial Results   Feb 21, 02 08:29 ET BTG Acquires New Class of Compounds with Potent Activity Against HIV   Feb 20, 02 08:30 ET U.S. Genomics to Collaborate with Dr. Pui-Yan Kwok, Leading Geneticist at Washington University, for Genetic Research, Technology Development   Feb 19, 02 09:51 ET Neurochem Receives U.S. Patent for Amyloid Program   Feb 12, 02 10:20 ET BioStratum Successfully Files IND for Anticancer Product Angiocol (TM), Receives Clearance to Initiate Phase I Clinical Trial   Feb 08, 02 02:00 ET GeneProt Licences OGS' Automated Proteomics Patents   Feb 07, 02 07:01 ET OGS Opens New Office in New Jersey   01:00 ET BioMarin to Consolidate Share Structure by Acquiring Glyko Biomedical   Feb 01, 02 01:00 ET ZymoGenetics, Inc. Announces Initial Public Offering of Common Stock   Jan 29, 02 12:15 ET Neurochem Scientists Release Findings on In Vivo Inhibition of Amyloid Formation and Deposition in Alzheimer's Disease Research Program   Jan 28, 02 08:30 ET U.S. Genomics and The Wellcome Trust Sanger Institute to Collaborate on Genetic Discovery   Jan 24, 02 09:04 ET James J. Cappola, M.D, Ph.D. Joins NitroMed as Senior Vice President Clinical and Regulatory Affairs   Jan 22, 02 09:04 ET Gardiner F.H. Smith Named Vice President, Business Development of Memory Pharmaceuticals   Jan 15, 02 09:00 ET Restoragen, Inc. Appoints Ashleigh W. Palmer as Chief Executive Officer   Jan 14, 02 09:38 ET BioMarin to Acquire Developer of Unique Brain Delivery Technology   Jan 09, 02 02:00 ET Oxford GlycoSciences, Medarex and Genmab Announce Comprehensive Campaign To Treat Breast Cancer   Jan 08, 02 08:59 ET NitroMed Appoints Former Novartis CEO Jerry Karabelas, Ph.D. to Board of Directors   Jan 04, 02 16:00 ET BioMarin Announces Personnel Changes   08:59 ET ZymoGenetics Appoints Dr. Mark Young as Senior Vice President, Technical Operations   Jan 02, 02 08:30 ET Therion Biologics and the Ludwig Institute Initiate Clinical Study of Cancer Vaccine in Europe   Dec 26, 01 09:01 ET Altus Completes Second Round of Private Financing, Totaling Over $50 Million   Dec 17, 01 08:32 ET Applied Molecular Evolution Appoints James B. Breitmeyer, M.D., Ph.D. Chief Medical Officer   Dec 14, 01 02:01 ET OGS Announces Extension of Proteomics Agreement with Pfizer   Dec 13, 01 01:00 ET BioMarin Completes $96.6 Million Public Offering of Common Stock   Dec 12, 01 08:59 ET Feinstein Kean Healthcare Appoints Michael Lampe to Director in Marketing and Scientific Communications Group   Dec 07, 01 09:14 ET BioMarin Prices $84 Million Public Offering of Common Stock   Dec 06, 01 19:33 ET OGS Announces Achievement of Major Protein Patenting Milestone   Dec 03, 01 09:02 ET ZymoGenetics Appoints Robert S. Whitehead as Chief Business Officer   Nov 30, 01 06:15 ET Aradigm Corporation Announces Appointment of Bryan Lawlis as Chief Operating Officer and the Departure of Igor Gonda as Chief Scientific Officer   Nov 27, 01 07:59 ET Therion Biologics Strengthens Position in Cancer Immunotherapy with Acquisition of Key Patents from the U.S. Public Health Service   Nov 26, 01 08:29 ET Keryx President, Benjamin Corn, M.D., Assumes Additional Role Of Chief Executive Officer   Nov 20, 01 02:00 ET OGS Enters Exclusive Alliance with Teva for the Marketing and Distribution of Vevesca (OGT 918) in Israel   Nov 15, 01 12:33 ET BioStratum Incorporated to Present at BIO-Scandinavia 2001   08:29 ET U.S. Genomics Appoints David Hoey as Vice President of Business Development   Nov 14, 01 09:05 ET Icagen Expands Senior Management Team   Nov 13, 01 11:01 ET Neurochem's Data Show Early Inflammatory Response during Amyloid Deposition in Alzheimer's Disease Model   08:30 ET Keryx Reports Third Quarter 2001 Financial Results   Nov 09, 01 17:27 ET BioMarin Announces Filing of Registration Statement with SEC   08:59 ET ZymoGenetics to Discuss Novel Therapeutic Approaches for the Treatment of Autoimmune Disease   07:59 ET U.S. Patent Issued for Neurochem   Nov 07, 01 12:32 ET VITEX Speaks at the World Health Organization's Forum on Blood Safety   Nov 06, 01 09:25 ET BioMarin Completes Acquisition of Enzyme Products From IBEX Technologies   08:20 ET Applied Molecular Evolution, Inc. Reports Financial Results for the Third Quarter 2001   Nov 01, 01 10:21 ET ** November Is National Alzheimer's Disease Month ** New Nationwide Survey of More Than 2,500 People Uncovers Barriers to Early Detection of Alzheimer's Disease   Oct 31, 01 11:53 ET AACR-NCI-EORTC International Conference Highlights Therion Vaccines as Innovative Approach to Cancer Immunotherapy   08:29 ET U.S. Genomics Appoints Michael B. Olex as Senior Vice President of Operations and Manufacturing   08:29 ET VITEX Reports Third Quarter 2001 Financial Results   Oct 30, 01 10:57 ET BioStratum Incorporated to Present at AACR-NCI-EORTC International Conference   10:15 ET Hematech Relocates Research Laboratory to Sioux Falls, South Dakota   09:18 ET Coley Pharmaceutical Group Begins Phase I/II Trial of CpG 7909 in Combination with Herceptin (R) to Treat Breast Cancer   07:59 ET Therion Completes $36.5 Million Private Financing to Advance Clinical Development of Therapeutic Cancer Vaccines   Oct 26, 01 10:36 ET Study Results Suggest Dexmethylphenidate HCl Is An Effective Treatment For ADHD   09:48 ET New Data Suggest Ritalin(R) LA (Methylphenidate Hydrochloride Extended-Release Capsules) is an Effective Once-Daily Treatment For ADHD   01:01 ET BioMarin Announces Third Quarter 2001 Financial Results   Oct 25, 01 13:47 ET VITEX to Present at Massachusetts Opportunities Investment Conference on October 30   10:01 ET BioStratum Names Seymour Mong, Ph.D., Vice President of Research   Oct 24, 01 11:31 ET Neurochem Announces Clinical Advisory Board for Promising Alzheimer's Therapeutic   10:01 ET Colbar's Second Tissue Engineering Product, Dermicol, To Enter U.S. Clinical Trials In 2002   09:30 ET Feinstein Kean Healthcare Announces Promotion of Mark Alvino to Senior Vice President   Oct 22, 01 17:21 ET INACTINE(TM) System Inactivates Virus that Causes Foot and Mouth Disease   12:45 ET VITEX to Announce Third Quarter 2001 Financial Results on October 31, 2001   09:03 ET Icagen and Bristol-Myers Squibb Renew Drug Discovery and Development Collaboration   Oct 17, 01 02:00 ET Vevesca (OGT 918) Accepted for Filing by FDA   Oct 16, 01 08:59 ET Nationwide Survey of More Than 2,500 People Uncovers Barriers To Early Detection Of Alzheimer's Disease   Oct 15, 01 14:13 ET Neurochem Receives $1.4 Million Grant from FDA and OMP Designation in Europe for Fibrillex(TM)   08:33 ET INACTINE(TM) System May Eliminate Need to Gamma Irradiate Cells For TAGvHD Prevention   Oct 10, 01 01:00 ET BioMarin To Acquire Enzyme Products From IBEX Technologies   Oct 09, 01 20:55 ET INACTINE(TM) System May Address Concerns of Prion Proteins in Red Blood Cells   08:29 ET VITEX to Present at UBS Warburg Global Life Sciences Conference on October 12   Oct 04, 01 09:59 ET BioStratum Incorporated to Present at UBS Warburg Global Life Sciences Conference   Oct 03, 01 10:46 ET Altus Raises $35 Million in Private Financing   08:29 ET Keryx Appoints Barry Cohen to Vice President of Business Development   Oct 02, 01 09:37 ET Ritalin (R) LA, a New Once-Daily Treatment for ADHD, Receives FDA Approvable Letter   Sep 26, 01 08:59 ET Psychiatric Genomics, Inc. Appoints New Chief Financial Officer   Sep 24, 01 02:01 ET Oxford GlycoSciences Plc Interim Results for the Six Months Ended 30 June 2001   02:00 ET Latest Clinical Results on OGT 918 for Gaucher Disease in Long-Term Follow Up and Dose Comparison Studies Presented at ESGLD Meeting   Sep 20, 01 08:31 ET Keryx Appoints Professor Rony Seger, Ph.D. as its Chief Scientific Officer   Sep 18, 01 08:29 ET Applied Molecular Evolution to Optimize Anti-IL-9 Antibody For MedImmune   07:59 ET RTP Pharma Inc. Enters Exclusive Alliance With Baxter Healthcare Corporation On RTP Pharma Inc.'s Injectable IDD (TM) Technology   Sep 11, 01 08:04 ET Memory Pharmaceuticals Acquires Rights From Bayer to a Promising Drug Candidate for Dementia   06:01 ET Restoragen, Inc.'s Betatropin(TM) Improves Glucose Levels In Type 2 Diabetics Over 7-Day Treatment Period   Sep 10, 01 13:50 ET ZymoGenetics, Inc. Files Registration Statement for an Initial Public Offering of Common Stock   Sep 06, 01 08:30 ET Keryx Biopharmaceuticals Granted Fast Track Status by the U.S. Food and Drug Administration   01:00 ET BioMarin Announces Positive MPS VI Phase I Trial Results   Sep 05, 01 08:29 ET Applied Molecular Evolution Awarded $1 Million NIH Research Grant for the Treatment of Cocaine Overdose and Addiction   08:00 ET Tony Scullion Named Chief Executive Officer of Memory Pharmaceuticals   Sep 04, 01 01:00 ET ZymoGenetics and Serono to Collaborate on a Novel Therapeutic Approach For Autoimmune Disease   Aug 28, 01 08:31 ET Applied Molecular Evolution Names Stanley T. Crooke, M.D., Ph.D., to Its Board of Directors   Aug 23, 01 06:15 ET Aradigm Corporation Announces $14.6 Million Private Placement   Aug 22, 01 10:46 ET Novartis and Celgene Receive FDA Approvable Letter for Dexmethylphenidate HCl, the First Chemically Advanced Form of Ritalin (R) for ADHD   08:31 ET Therion Expands Clinical Capabilities with Appointment of Two Senior Executives   02:11 ET OGS Announces Grant of Expanded High-Throughput Proteomics Patent   Aug 21, 01 11:29 ET OGS announces completion of New Drug Application submission for Vevesca(TM) (OGT 918) with the US Food and Drug Administration   Aug 16, 01 14:02 ET Plaintiffs' Attorneys Drop Ritalin Class Action Litigation in Puerto Rico   Aug 15, 01 09:02 ET SafeScience, Inc. Reports Second Quarter 2001 Financial Results   Aug 14, 01 08:35 ET VITEX Reports Second Quarter 2001 Financial Results   06:02 ET VITEX Completes Divestiture of Plasma Operations   Aug 13, 01 09:37 ET Keryx Reports Second Quarter 2001 Financial Results   Aug 07, 01 08:29 ET Applied Molecular Evolution, Inc. Reports Financial Results for the Second Quarter 2001   08:29 ET VITEX to Announce Second Quarter 2001 Financial Results on August 14, 2001   Aug 06, 01 14:07 ET Spherics Appoints David J. Livingston, Ph.D., MBA, as President and Chief Executive Officer   Aug 01, 01 08:02 ET SkyePharma Acquires 40.2% Interest in RTP Pharma Inc   Jul 31, 01 08:29 ET Novasite Pharmaceuticals Enters Small Molecule Discovery Agreement With Aventis Pharmaceuticals   Jul 27, 01 01:00 ET BioMarin Announces Second Quarter 2001 Financial Results   Jul 26, 01 16:58 ET VITEX to Present at Adams, Harkness & Hill's 21st Annual Summer Seminar   06:01 ET Third Wave Reports Second Quarter Results   01:01 ET BioMarin Completes Treatment Stage of MPS-VI Trial   Jul 25, 01 02:00 ET OGS Announces Development of Second Generation Proteomics Platform   Jul 23, 01 08:59 ET Plaintiffs' Attorneys Walk Away from Ritalin Litigation in Florida   08:59 ET Potential for Huge Rewards but High Risks Identified in The Boston Consulting Group's Report on Genetics in Drug Research and Development   08:59 ET SafeScience Completes Patient Enrollment For Phase II Pancreatic Cancer Clinical Trial   Jul 19, 01 09:04 ET ZymoGenetics Names George B. Rathmann as Chairman of the Board   08:59 ET Third Wave Technologies to Host Second-Quarter 2001 Conference Call   08:00 ET Nycomed Amersham Imaging and Neurochem Collaborate to Create Alzheimer's Diagnostic   Jul 18, 01 12:14 ET U.S. Genomics Awarded Patent Using Fluorophores in Direct, Linear DNA Analysis   08:59 ET SafeScience, Inc. Retains Nasdaq Smallcap Market Listing   08:07 ET BioMicro Systems Receives U.S. Patent Allowance For Microfluidic Passive Fluid Control Technology   Jul 17, 01 07:02 ET ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 2001   02:00 ET Neurochem Provides Update on Clinical Treatment for Secondary Amyloidosis   Jul 13, 01 02:01 ET OGS Initiates Vevesca(TM) Clinical Study At New York University -- Acknowledged 'Centre of Excellence' for The Diagnosis and Treatment of Gaucher Disease   Jul 12, 01 02:01 ET OGS' Marketing Authorisation Application for Vevesca(TM) (OGT 918) Accepted for Review by European Agency   Jul 11, 01 12:51 ET SafeScience Closes Business Venture Transaction   Jul 10, 01 17:27 ET ArQule, Inc. to Report Second Quarter Financial Results on July 17, 2001   08:37 ET VITEX Added to the Russell 3000 Index   08:31 ET Applied Molecular Evolution Added to Russell 3000 Index   Jul 06, 01 08:29 ET Coley Pharmaceutical Group Publishes Discovery of Novel Interferon-Inducing CpG Molecule in European Journal of Immunology   Jul 05, 01 09:01 ET Restoragen, Inc. Reports Positive Results From Trials of Betatropin(TM) in Type 2 Diabetics   Jul 02, 01 06:01 ET Third Wave Scientists Publish Advance In Gene Expression Monitoring With Revolutionary RNA Invader(R) Assay   Jun 29, 01 17:21 ET SafeScience Signs Definitive Agreements For Joint Venture   Jun 26, 01 08:31 ET Applied Molecular Evolution Files Patent Infringement Suit Against MorphoSys   Jun 25, 01 01:00 ET BioMarin Files CTX to Conduct Clinical Trial of Vibriolysin Topical to Treat Serious Burns   Jun 21, 01 12:00 ET UroGenesys Changes Name to Agensys and Expands into Therapeutic Product Development   07:26 ET MorphoSys and ImmunoGen Expand Existing Collaboration License of HuCAL(R) For Target Research   Jun 20, 01 09:02 ET SafeScience Receives Conditional Registration for Elexa 4(R) Plant Defense Booster   02:01 ET OGS and NeoGenesis Announce High-Throughput, 'Target-to-Drug Lead' Collaboration   Jun 15, 01 02:00 ET Marconi and OGS Form Joint Venture to Provide Proteomics Data And Hosting Solutions   02:00 ET OGS Building 'Protein Atlas' to Provide First Definitive List and Structure of Human Protein-Coding Genes   Jun 14, 01 08:59 ET NitroMed Completes $31.4 Million Private Financing   Jun 13, 01 19:35 ET SafeScience, Inc. Forms Business Venture With Elan Corporation, Plc.   19:33 ET SafeScience, Inc. Receives Nasdaq Staff Determination and Requests Appeal   08:31 ET U.S. Genomics Receives First U.S. Patent for Molecular Motors   Jun 11, 01 08:29 ET Ronald J. Saldarini, Ph.D. Elected Chairman of Therion Board of Directors   Jun 07, 01 12:39 ET ArQule Announces Appointments of Vice President, Strategic Development and Vice President, Legal   08:15 ET ArQule Announces Appointment of Ariel Elia As Chairman of the Board of Directors   Jun 06, 01 08:59 ET Novasite Pharmaceuticals Launches GPCR Crystallization Effort Led by Dr. Krzysztof Palczewski   Jun 05, 01 08:32 ET Applied Molecular Evolution to Present at the Wall Street Analyst Forum on June 6th 2001   06:59 ET ZymoGenetics and BioMimetic Pharmaceuticals Sign Licensing Agreement for Clinical Development of PDGF   Jun 04, 01 10:48 ET Boston Consulting Group Quantifies Benefits of Genomic Technologies for Streamlined Drug Discovery   May 31, 01 10:22 ET FDA Grants Marketing Clearance For Oral Suspension of Trileptal (R) For Epilepsy (Seizure Disorder)   May 29, 01 07:01 ET British Biotech and ImmunoGen Begin Patient Enrollment for the Phase I/II Trial of BB-10901/huN901-DM1 in Small Cell Lung Cancer   May 24, 01 08:00 ET ArQule, Inc. to Webcast Analyst Day on May 30, 2001   May 23, 01 08:31 ET Point Therapeutics Receives $5.4 Million to Advance Clinical Tests of Small Molecule Treatment of Neutropenia in Cancer Patients   May 22, 01 09:04 ET Delta Pharmaceuticals Changes Name to Ardent Pharmaceuticals   07:01 ET Dyax Corp. and American Home Products Enter Into Exclusive License for Use of a Ligand for Purification of FVIII   May 18, 01 15:31 ET Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin   11:26 ET The Biotechnology Institute Launches Special Issue of Your World on the Human Genome   May 17, 01 17:45 ET SafeScience, Inc. Reports First Quarter 2001 Financial Results   12:53 ET BioMarin Announces $45 Million Private Placement   May 16, 01 08:14 ET Phytera and Gemin X Sign Cancer Drug Discovery Collaboration   May 15, 01 08:33 ET Keryx Reports First Quarter 2001 Financial Results   May 14, 01 16:01 ET Georgetown Researchers Achieve Increased Cancer Patient Survival Following Treatment with Therapeutic Vaccines   12:13 ET ImmunoGen, Inc. Announces Webcast for Its Analyst Briefing Held at the 2001 Annual Meeting of the American Society of Clinical Oncology   07:34 ET ImmunoGen Reports Promising Results from Phase I/II Human Clinical Study with Product Candidate for Colorectal, Pancreatic and Non-Small-Cell Lung Cancers   May 11, 01 09:32 ET Applied Molecular Evolution Adopts Stockholder Rights Plan   08:31 ET In New Study, Rapid Switching From Donepezil to Rivastigmine Was Well Tolerated; Findings Presented at The American Geriatrics Society Annual Meeting in Chicago   May 10, 01 16:25 ET ImmunoGen, Inc. Reports Third Quarter Results, Beating Expectations by $0.01   08:29 ET Vitex Reports First Quarter 2001 Financial Results   01:01 ET BioMarin and Genzyme Report Continued Improvements in MPS-I Patients After 2 Years of Treatment with Aldurazyme (TM)   May 08, 01 13:01 ET VITEX to Announce First Quarter 2001 Results on May 10, 2001   09:18 ET ImmunoGen Begins Enrollment in a Third Phase I/II Human Clinical Study with Lead Product for Colorectal, Pancreatic and Non-Small-Cell Lung Cancers   May 07, 01 07:30 ET Vitex and Oxford University to Collaborate on Promising Prion Technology   May 03, 01 07:25 ET ImmunoGen Schedules Third Quarter 2001 Financial Results on May 10, 2001   May 01, 01 08:32 ET Icagen Expands Senior Management Team   08:29 ET Applied Molecular Evolution, Inc. Reports Financial Results For the First Quarter 2001   Apr 27, 01 08:28 ET Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin   01:00 ET BioMarin Announces First Quarter 2001 Financial Results   Apr 26, 01 17:43 ET Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin   10:01 ET BioStratum Incorporated Adds Former Glaxo President D'Alonzo and Memorial Sloan-Kettering President Emeritus Marks to Board of Directors   08:35 ET Hyseq Announces First Quarter Financial Results   06:59 ET Dyax Corp. Announces First Quarter 2001 Financial Results   Apr 25, 01 08:36 ET Hyseq Appoints Two Top Executives: Senior Vice President and Chief Financial Officer, Peter S. Garcia and Senior Vice President of Human Resources, Linda A. Fitzpatrick   Apr 24, 01 07:59 ET BioMarin Completes Important Milestone in the Manufacturing of Aldurazyme (TM)   Apr 18, 01 13:30 ET Dyax Corp. to Host First Quarter Conference Call   08:29 ET BioStratum Incorporated Elects Harry H. Penner to Board of Directors   Apr 12, 01 09:16 ET Novartis' Alzheimer's Disease Web Site Receives Awards for Content, Interactive Design and Best Pharmaceutical Site   Apr 05, 01 02:00 ET OGS and the Institute for Systems Biology Announce ICAT based Proteomics Platform Alliance   Apr 04, 01 11:45 ET SafeScience Reports 2000 Year-End and Fourth Quarter Financial Results   08:59 ET U.S. Genomics Announces $17 Million Private Financing to Advance Pioneering Technology for Direct, Linear Analysis of DNA   Apr 03, 01 10:08 ET ImmunoGen, Inc. Announces Webcast of Presentation at Tucker Anthony Sutro's Health Care Conference 2001   10:03 ET PTC Therapeutics Inc. Announces Appointments to Board of Directors   Mar 29, 01 11:23 ET Keryx Reports Fourth Quarter and Year End 2000 Financial Results   07:29 ET ImmunoGen and Raven Biotechnologies Announce Target and Antibody Discovery Collaboration in Ovarian Cancer   Mar 27, 01 16:53 ET Icagen Raises $23 Million to Advance Ion Channel Drug Discovery and Development Programs   Mar 23, 01 08:30 ET SafeScience Announces Cancer Drug Shows Positive Activity in Phase II Clinical Trial   Mar 21, 01 08:31 ET Hyseq Promotes Ted W. Love as CEO and President George B. Rathmann to Remain as Chairman   Mar 20, 01 09:20 ET Pyrosequencing AB and Mosaic Technologies Enter Cross-License Agreement To Leverage DNA Sequencing technologies   08:31 ET IAVI and Therion Form Collaboration to Advance Preventative Vaccines for AIDS   Mar 19, 01 09:59 ET Ardais Raises $33.5 Million in Private Financing   02:01 ET XTL Biopharmaceuticals Ltd Receives Milestone Payments From Corporate Partner for Use of Trimera System   Mar 17, 01 17:30 ET NitroMed Initiates Confirmatory BiDil (R) Trial in African American Heart Failure Patients   Mar 15, 01 08:29 ET Pyrosequencing AB Announces Major Improvement in Efficiency For Allele Frequency Studies   02:01 ET Oxford GlycoSciences Plc Preliminary Unaudited Results for the Year Ended 31 December 2000   Mar 14, 01 16:20 ET Judge Dismisses Complaint Against Makers of Ritalin   09:47 ET Judge Dismisses Complaint Against Makers of Ritalin   Mar 13, 01 17:49 ET Judge Dismisses Complaint Against Makers of Ritalin   08:31 ET Oxford GlycoSciences to Host Fourth Quarter 2000 Conference Call   08:29 ET Second Generation Vitaxin Enters Phase I Clinical Trials with MedImmune   Mar 12, 01 08:29 ET EPIX Medical, InSightec and Brigham and Women's Hospital Enter Technology Development Collaboration   Mar 09, 01 08:41 ET VITEX Signs Letter of Intent to Divest Plasma Operations   02:00 ET XTL Biopharmaceuticals Acquires Stake in iviGene Corporation   Mar 08, 01 15:37 ET Applied Molecular Evolution to Present at the Informed Investors San Diego Biotechnology Stocks Forum   10:01 ET Biostratum Names Gary M. Gordon, MD, Vice President of Business Development   07:59 ET NitroMed Receives FDA Letter on BiDil (R) NDA, a Treatment for Heart Failure in Black Patients   07:01 ET Dyax Corp. Announces Management Changes   Mar 07, 01 09:04 ET Cystic Fibrosis Foundation Announces $25 Million Alliance with Altus Biologics Inc. in Developing Treatment for Pancreatic Insufficiency   08:29 ET Abbott Laboratories and Icagen Extend and Expand Drug Discovery Collaboration   Mar 06, 01 08:29 ET Applied Molecular Evolution, Inc. Reports Financial Results for the Fourth Quarter and Year End 2000   Mar 05, 01 16:20 ET Alzheimer's Disease Expert and ABC Television Personality Linda Dano Available For Interviews   15:29 ET Exelon (R) (rivastigmine tartrate) Fact Sheet   15:26 ET Linda Dano and the National Family Caregivers Association Team Up to Provide Information, Resources and Support to Caregivers of Alzheimer's Disease Patients   08:31 ET Alan Carpenter, Ph.D. Joins EPIX Medical as E.V.P. of Research and Development   08:30 ET VITEX Completes $10 Million Equity Placement   08:04 ET Hematech Receives Milestone Payment from its Polyclonal Antibody Collaboration with Kirin   07:35 ET ImmunoGen Appoints New Chief Financial Officer   Mar 02, 01 01:00 ET BioMarin Announces Completion of Enrollment of Phase III Trial of Aldurazyme (TM) for MPS-I   Feb 28, 01 07:01 ET Dyax Signs 50th Licensee for Phage Display   Feb 27, 01 09:01 ET Feinstein Kean Healthcare Expands and Strengthens Senior Account Staff   Feb 23, 01 17:08 ET SafeScience, Inc. Discontinues Consumer and Commercial Product Lines to Focus on Drug Development   Feb 22, 01 08:29 ET Maret Pharmaceuticals Appoints Leonard R. Borrmann, Pharm.D., as Chief Executive Officer   07:01 ET Dyax Corp. Announces Fourth Quarter and Year End 2000 Financial Results   01:00 ET BioMarin Announces Fourth Quarter and Year 2000 Financial Results   Feb 21, 01 09:02 ET Anadys Pharmaceuticals Establishes German Operations To Access RNA Biology Through EMBL   Feb 20, 01 16:04 ET Therion Biologics and National Cancer Institute Initiate Human Clinical Trials of Next-Generation Product for Colorectal Cancer   08:32 ET Repair's President and CEO to Speak at BIO CEO & Investor Conference in New York   08:29 ET VITEX Appoints Joseph M. Limber To Its Board of Directors   Feb 16, 01 13:49 ET Dyax Corp. to Host Fourth Quarter and Year End 2000 Conference Call   12:15 ET Applied Genomics to Take Spotlight at Showcase Meeting   08:35 ET Hyseq CFO Announces Resignation to Pursue Other Opportunities   08:01 ET Hematech Appoints James Robl, Ph.D. President and Chief Scientific Officer   Feb 15, 01 16:06 ET EPIX Medical Reports Fourth Quarter and Year-End Results for 2000   08:29 ET SafeScience, Inc. Forms New Scientific Advisory Board   Feb 14, 01 17:21 ET ArQule To Present at the BIO CEO & Investor Conference   Feb 13, 01 14:01 ET UroGenesys Researchers Report Antibodies to Prostate Cancer Target Block Tumor Growth, Inhibit Metastases and Prolong Survival in Mice   13:01 ET Neurochem Reports Key Data on Role of Inflammation in Alzheimer's Disease   08:29 ET VITEX Reports Fourth Quarter and Year-End Results for 2000   06:59 ET Dyax Corp. and Debiopharm S.A. Report Initiation of Phase II Clinical Trial With EPI-HNE-4 for Cystic Fibrosis   Feb 12, 01 08:10 ET Keryx Awarded Critical U.S. Patent For Gene-Based Drug Discovery Involving Kinase Targeted Compounds   02:00 ET OGS Reports Progress with Vevesca(TM) Clinical Trials in Type 1 Gaucher Disease   Feb 09, 01 14:54 ET VITEX to Report Fourth Quarter and Year-End Results on February 13, 2001   Feb 08, 01 16:24 ET ImmunoGen, Inc. Reports Second Quarter Results   16:11 ET EPIX Medical CEO Joins Board of Medical Imaging Contrast Agents Association (MICAA)   08:05 ET Hyseq Announces Financial Results for The Fourth Quarter and Year Ended December 31, 2000   Feb 07, 01 09:22 ET Genomica Reports Fourth Quarter and Year 2000 Financial Results   Feb 06, 01 10:01 ET BioStratum Signs License Agreement Granting Kowa Company Exclusive Rights to Diabetes Drug Candidate in Japan and Selected Other Asian Markets   08:31 ET Keryx Biopharmaceuticals Appoints J. Wilson Totten, M.D. and Malcom I. Hoenlein to Board of Directors   Feb 05, 01 13:33 ET ImmunoGen, Inc. Announces Second Quarter Conference Call   08:30 ET Applied Molecular Evolution Names John F. Richards to its Board of Directors   07:01 ET Aradigm and Genentech Discontinue AERx (R) rhDNase Development Program and Will Execute New Broad-Based Feasibility Agreement   Feb 01, 01 13:21 ET ImmunoGen Comments on Recent SEC Lawsuit   08:59 ET CoPharma Announces Licensing Agreement with Dana-Farber Cancer Institute   07:30 ET BioMarin Announces Equity Financing Commitment of up to $50 Million   07:01 ET ArQule, Inc. Announces the Close of its Merger with Camitro Corporation   Jan 31, 01 11:40 ET Genomica Corporation to Report Fourth Quarter Earnings on February 7, 2001   08:59 ET Pan Pacific Pharmaceuticals, Inc. Appoints U.S. Scientific Advisory Board   07:59 ET ZymoGenetics Appoints James A. Johnson as Chief Financial Officer   Jan 30, 01 08:59 ET U.S. Patent Issued for RTP Pharma   08:32 ET Lynx and Phytera Announce Partnership to Identify Genes for Biosynthesis of Important Nutraceutical Compounds   Jan 29, 01 09:38 ET Pyrosequencing AB Extends Global Market Access With New Distribution Agreements   09:02 ET SafeScience Secures Global Patent Portfolio For GBC-590 Through Exclusive World-Wide Licensing Agreement   09:02 ET SafeScience to Focus on Biotechnology and Drug Development   08:31 ET Keryx Biopharmaceuticals Secures U.S. Patent For Use of KRX-101 Against Diabetic Retinopathy   Jan 25, 01 08:29 ET Hyseq Announces Markman Decision in Litigation Brought by Affymetrix Ruling Supports Hyseq's Defenses   07:50 ET ImmunoGen and Avalon Enter Genomics-Based Collaboration   06:59 ET Dyax Corp and Debiopharm S.A. Report Preliminary Results of Phase Ib Clinical Trial of EPI-HNE-4 for Cystic Fibrosis   Jan 24, 01 07:04 ET ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended 2000 And Extension of Collaboration with Solvay Pharmaceuticals   Jan 23, 01 08:31 ET Phytera Achieves Milestone from Lilly Anti-fungal Drug Discovery Collaboration   Jan 22, 01 02:01 ET XTL Biopharmaceuticals and Dyax Collaborate to Unite Two Powerful Drug Discovery Technologies   Jan 18, 01 08:30 ET BioMarin and Genzyme Report Publication in the New England Journal of Medicine of Treatment with Aldurazyme (TM) in MPS-I Patients   Jan 17, 01 08:30 ET Merlin Technologies Appoints Raymond Baddour to Board of Directors   08:01 ET Corixa and CoPharma Collaborate to Develop and Commercialize Corixa's Novel Cardioprotectant   Jan 16, 01 17:19 ET ArQule and Camitro Agree to Merge   12:10 ET Dr. Ted Love Joins Hyseq as President   08:29 ET SafeScience, Inc. Announces $4.7 Million Private Placement of Securities   07:01 ET ArQule and Nanodesign Enter into Collaboration for Novel Drug Design Technology   Jan 12, 01 16:33 ET Applied Molecular Evolution to Host Analyst Event   08:29 ET ZymoGenetics Researchers Identify Novel Protein with Potential Role in Psoriasis   Jan 11, 01 11:01 ET BioMarin Exercises Option to Acquire Exclusive Rights to Proprietary Burn Product Candidate   Jan 09, 01 08:32 ET Schering AG Germany Acquires Japanese Rights to EPIX Medical's MS-325   Jan 08, 01 07:05 ET Dyax Corp. and Human Genome Sciences Enter into Exclusive BLyS Purification License   07:01 ET Lexicon Genetics Announces Milestone in LexVision(TM) Collaboration With Bristol-Myers Squibb   07:00 ET Abgenix and Dyax to Collaborate on Novel Antibody Technology   Jan 05, 01 06:59 ET Lexicon Genetics Names Key Individuals to Lead Human Resources and Corporate Communications Functions   Jan 04, 01 11:01 ET BioMarin Receives European Orphan Drug Designation for rhASB for MPS-VI   08:45 ET Dyax to Present Company Update at the JP Morgan Chase 19th Annual Healthcare Conference   08:36 ET Vitex and Pall Initiate Phase II Trial for Inactine(TM) Pathogen Inactivation For Red Blood Cells   Jan 03, 01 07:01 ET Lexicon Genetics and Abgenix Enter Drug Target Validation Collaboration   Dec 21, 00 08:30 ET Ischemia Technologies Completes Series B Equity Financing   Dec 20, 00 12:29 ET EPIX Medical Clarifies Inaccurate Information Regarding Possible Sale of Stock   09:05 ET Applied Molecular Evolution Enters Collaboration With Biosynexus to Optimize an Antibacterial Agent   02:01 ET XTL Biopharmaceuticals Ltd Reports Update From Preclinical Hepatitis C Virus Program and Hepatitis B Virus Clinical Trial   Dec 19, 00 08:45 ET PTC Therapeutics Awarded Phase I SBIR Grant to Develop Novel HIV Treatments   07:00 ET ArQule and ACADIA Pharmaceuticals Establish new Drug Discovery Collaboration   07:00 ET Lexicon Genetics Grants Roche Bioscience Renewal to Technology Sublicense   Dec 18, 00 10:31 ET New Findings Published In The Lancet Suggest Exelon (R) (rivastigmine tartrate) Improves Behavioral Disturbances In Patients With Dementia With Lewy Bodies   Dec 13, 00 10:08 ET PTC Therapeutics Inc. Announces Appointments to Scientific Advisory Board and Senior Management Team   Dec 12, 00 08:59 ET Anadys Pharmaceuticals Raises $21.2 Million In Private Financing   Dec 05, 00 13:15 ET First Human Data Presented for Vitex's Pathogen Inactivated Red Blood Cell Product at ASH Conference   13:01 ET First Human Data Reported on Safety and Viability of Virally Inactivated Red Blood Cells   Dec 01, 00 10:02 ET Linda Dano Reaches Out to Help Other Alzheimer's Disease Caregivers   09:20 ET Applied Molecular Evolution, Inc. Announces Stock Repurchase   Nov 29, 00 14:04 ET ArQule, Inc. Announces Exercise of Underwriters' Overallotment Option   08:29 ET Keryx Biopharmaceuticals Appoints Ron Bentsur Global Head of Investor Relations   Nov 28, 00 06:55 ET ArQule Announces Drug Discovery Collaboration with SmithKline Beecham   02:00 ET XTL Biopharmaceuticals Announces Issuance of Human Monoclonal Antibody Patent   Nov 27, 00 08:29 ET Dr. James Hope Joins Vitex as VP, Molecular Sciences   Nov 22, 00 12:31 ET Genzyme and Biomarin Announce PHASE III Trial of Aldurazyme(TM) For MPS-I   Nov 21, 00 12:21 ET ArQule, Inc. Announces Closing of Follow-On Public Offering   08:01 ET Harvard Center For Cancer Prevention Purchases Pyrosequencing's PSQ(TM) 96 System For DNA Analysis   Nov 20, 00 08:31 ET Deloitte & Touche Ranks Vitex 51st Out of 500 Fastest Growing Technology Companies   Nov 16, 00 09:30 ET Feinstein Kean Healthcare Expands and Strengthens Management Team   08:29 ET Vitex Strengthens Executive Management From Within   07:55 ET ImmunoGen Announces Pricing of Public Offering   06:59 ET Lexicon Genetics Sublicenses Positive-Negative Selection and Isogenic DNA Technologies to Eli Lilly and Company   Nov 15, 00 18:22 ET Ischemia Technologies Secures 6.8 MM in Series B Equity Financing   16:01 ET Paradigm Genetics and LION Bioscience Expand Strategic Alliance   10:49 ET Paradigm Genetics and LION Bioscience Expand New Strategic Alliance   Nov 14, 00 16:39 ET SafeScience Inc. Reports Third Quarter 2000 Financial Results   10:31 ET XTL Biopharmaceuticals and Pharming Group to Co-Develop Lactoferrin to Treat Hepatitis C   08:29 ET Keryx Reports Third Quarter 2000 Financial Results   Nov 13, 00 12:17 ET EPIX Medical's MS-325 Contrast Agent Provides Detailed MRI Images of Artery Walls   10:19 ET Indiana University Patient Trial Shows Cholinesterase Inhibitor Delays Progression of Mild to Moderately Severe Alzheimer's Disease   08:29 ET EPIX Announces Study Results for First MRI Contrast Agent Targeted at Imaging Blood Clots   08:08 ET SafeScience, Inc. to Host Third Quarter 2000 Conference Call   07:01 ET Aquila and Baylor College of Medicine Announce the Initiation of Clinical Trials of QS-21 Flu Vaccine   Nov 10, 00 08:29 ET Maret Pharmaceuticals Presents Promising Phase I/II Clinical MARstem Results at International Symposium on New Drugs in Cancer Therapy   07:59 ET Genomica Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2000   07:09 ET ImmunoGen Reports Preliminary Phase I/II Clinical Data on huC242-DM1/SB-408075   Nov 09, 00 14:39 ET Urgent: Alert For Media Covering The American Heart Association (AHA) Annual Meeting   08:55 ET Vitex Reports Third Quarter 2000   Nov 08, 00 08:29 ET Vitex Submits Marketing Application in UK for Solvent Detergent Transfusion Plasma   07:29 ET ImmunoGen Reports Favorable Preclinical Results for huN901-DM1/BB-10901   Nov 07, 00 07:59 ET Aquila Biopharmaceuticals Reports Financial Results For the Third Quarter of 2000   06:59 ET Applied Molecular Evolution, Inc. Reports Financial Results for Third Quarter 2000   Nov 06, 00 07:59 ET Mosaic Technologies, Inc. to Host Symposium on Bacterial Contamination of Blood Components   07:01 ET Dyax and Bracco Announce Diagnostic Imaging Collaboration   Nov 03, 00 13:18 ET Triangle Pharmaceuticals to Host Analyst Event   09:29 ET Genomica Corporation to Report Third Quarter Earnings on November 10, 2000   08:32 ET INACTINE(TM) Pathogen Inactivation Highlighted at American Association Of Blood Banks Meeting   Nov 02, 00 12:36 ET Pyrosequencing Makes Forbes Global's List of 300 Best Small Companies   08:31 ET ZymoGenetics Researchers Identify Novel Interleukin that Plays Key Role in Immune System Regulation   08:01 ET Genomica's Discovery Manager (TM) Software Licensed to Aventis Pharma   07:01 ET Lexicon Genetics Announces Major Expansion in The Woodlands   07:00 ET Triangle Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter 2000   Nov 01, 00 13:25 ET NitroMed Issued Broad U.S. Patents Covering NO-Enhanced NSAIDs   08:59 ET Linda Dano and the National Family Caregivers Association Team Up To Provide Information, Resources and Support to Caregivers Of Alzheimer's Disease Patients   08:01 ET BioMarin Announces Election of New Chairman and Chief Executive Officer      07:59 ET Paradigm Genetics Announces Third Quarter 2000 Financial Results, Revenue Increases 829% Over 1999   Oct 31, 00 10:24 ET Pyrosequencing's PSQ (TM) 96 System DNA Sequencing Technology to Accelerate UC Davis Population Genetics Study   07:59 ET Psychiatric Genomics, Inc. Enters Next Phase of Development With Move to Larger Facilities   Oct 30, 00 07:01 ET BioMarin Announces Third Quarter 2000 Financial Results   07:01 ET Triangle Pharmaceuticals Reports Marked Anti-Hepatitis B Activity of Coviracil(R)(Emtricitabine)in Phase I/II Dose-Selection Trial   02:00 ET XTL Biopharmaceuticals Presents Interim Phase I Data on First Combination Monoclonal Antibody Therapy for Chronic HBV Infected Patients   Oct 26, 00 08:55 ET Hyseq Announces Third Quarter Results   08:21 ET Therion Biologics and Aventis Pasteur Expand Cancer Vaccine Alliance   07:45 ET ImmunoGen, Inc. Reports First Quarter Financial Results   06:59 ET Dyax Corp. Announces Third Quarter 2000 Financial Results   06:59 ET Lexicon Genetics Announces Third Quarter Financial Results   Oct 25, 00 08:30 ET Bartels Launches Legionella Urinary Antigen (LUA) ELISA Test Approved by FDA   07:59 ET Genomica Corporation Announces Launch of Java/Oracle-Based Linkmapper (TM) Software as Milestone in Applied Biosystems Alliance   07:04 ET Lexicon Genetics Announces Issuance of OmniBank Functional Genomics Patent   Oct 24, 00 14:48 ET Paradigm Genetics Appoints Christopher W.W. Beecher, Ph.D. As Director of Metabolic Profiling   11:37 ET Paradigm Genetics To Host Live Webcast of Third Quarter 2000 Financial Results Conference Call   08:34 ET Vitex Receives Fourth Patent for INACTINE(TM) Technology   08:29 ET Intracel Starts a Phase III Trial for KLH for the Treatment of Bladder Cancer   Oct 23, 00 14:05 ET Paradigm Genetics To Host Live Webcast of Third Quarter 2000 Financial Results Conference Call   07:01 ET ArQule Announces Filing of Registration Statement for Follow-On Offering   06:01 ET Novo Nordisk Completes Private Placement of Shares in ZymoGenetics   Oct 20, 00 08:29 ET AngioSense and Repair Enter Collaboration to Combine Angiogenesis and Needle- Free Delivery Device for Cardiovascular Disease   08:29 ET U.S. Environmental Protection Agency Approves Conditional Registaration of Elexa-4(R) From SafeScience   Oct 19, 00 16:51 ET EPIX Medical Reports Third Quarter 2000 Results   12:15 ET Paradigm Genetics Announces Certain Shareholders Sign New Lock-Up Agreement To Extend Lock-Up Period   08:00 ET Coley Pharmaceutical Group Initiates Phase II Clinical Trials of CpG Product   07:00 ET Aquila Initiates Additional Clinical Trials of Quilimmune-P (TM)   Oct 18, 00 06:59 ET Lexicon Genetics Grants Bristol-Myers Squibb Sublicense To Positive-Negative Selection and isogenic DNA Technologies   06:01 ET ArQule and Genome Therapeutics Establish New Collaboration for Discovery and Commercialization of Novel Anti-infective Therapeutics   Oct 17, 00 07:31 ET ImmunoGen Files Registration Statement for Stock Offering   Oct 16, 00 08:56 ET RHeoGene Receives $1.85 Million NIST Grant for Multiplexed Gene Regulation Technology   Oct 13, 00 22:28 ET Lexicon Genetics Sues Deltagen for Patent Infringement Under Four Additional United States Patents   Oct 12, 00 09:02 ET BioMarin Initiates Phase I/II Clinical Trial of Enzyme Replacement In MPS-VI Patients   06:29 ET ArQule, Inc. Reports Strong Financial Results for Third Quarter and Nine Months Ended September 30, 2000   05:30 ET Paradigm Genetics Meets Milestone by Delivering Customized Bioinformatics System to Bayer AG   Oct 10, 00 16:27 ET ArQule, Inc. to Report Third Quarter Earnings on October 12, 2000   12:29 ET Novasite Pharmaceuticals Awarded Second NIH Grant for $3.2 Million to Develop Expanded Target Drug Discovery(TM) Technology   08:59 ET CoPharma Appoints David Fanning Chief Business Officer   Oct 09, 00 16:17 ET EPIX Medical Clarifies Inaccurate Information Regarding Possible Sale of Stock   Oct 06, 00 09:01 ET Mosaic Technologies, Inc. Awarded $2 Million in Research Funding for High-Throughput DNA Sequencing System   Oct 05, 00 07:59 ET World-Renowned Karolinska Institute Adopts Pyrosequencing (TM) Technology For Disease-Related Research   07:01 ET Lexicon Genetics and Tularik Enter Into Functional Genomics Collaboration   Oct 02, 00 18:32 ET Vitex Approved for Phase II Inactine(TM) PEN110 Trials   10:26 ET MorphoSys Enters Cancer Collaboration with ImmunoGen   07:45 ET ArQule, Inc. Appoints Ariel Elia to Board of Directors   Sep 29, 00 08:29 ET Genomica Corporation Announces Pricing of Initial Public Offering   07:01 ET Lexicon Genetics Concludes Agreement With Merck Genome Research Institute   Sep 28, 00 08:59 ET Aradigm Reports Phase 2B Clinical Trial Initiated on AERx(R) Pain Management System   07:55 ET Coley Pharmaceutical Group Strengthens Leadership in Immune Stimulation With Acquisition of Key Patents from Isis Pharmaceuticals   07:29 ET Triangle Pharmaceuticals Announces Management Changes   Sep 27, 00 10:07 ET Genome Therapeutics Licenses Genomica's Discovery Manager(TM) Software   09:27 ET Keryx Biopharmaceuticals Provides Update on KRX-101 Clinical Development Program   08:31 ET Paradigm Genetics President and CEO John Ryals, Ph.D. Appointed To Biotechnology Industry Organization Executive Committee   Sep 26, 00 08:59 ET Novasite Pharmaceuticals Awarded Phase I SBIR Grant for Expanded Target Drug Discovery(TM) Technology   08:45 ET PTC Therapeutics Raises $15 Million to Develop Small Molecule Drugs Based on Integrated RNA Biology and Chemistry Platform   07:01 ET Vitex Names Samuel K. Ackerman, M.D., Chairman, Board of Directors David Tendler to Chair Executive Committee   Sep 22, 00 09:11 ET Biolink's Dialock(R) System Use and Acceptance Surge in Europe   Sep 21, 00 12:51 ET SafeScience Announces Completion of Enrollment for Phase II Colorectal Trial of GBC-590   12:22 ET MDS Proteomics Acquiring Protana, Creating the First Integrated and Fully Industrialized Functional Proteomics Company   09:21 ET David J. Enscore, Ph.D. Joins Spherics, Inc. as Vice President, Research and Development   08:01 ET National Cancer Center in Tokyo Implements Pyrosequencing(TM) Technology to Study Disease-Related DNA Sequences   07:30 ET Genaissance Pharmaceuticals Appoints Kenneth B. Kashkin, M.D. as Executive Vice President and Chief Medical Officer      07:29 ET HuC242-DM1/SB-408075 Enters Second Phase I/II Clinical Trial   Sep 19, 00 08:59 ET Domain Pharma Corporation Appoint Dean Goodermote Chief Executive Officer      07:59 ET Feinstein Kean Healthcare Announces Plans to Expand Operations with Opening of Denver Office in Early 2001   07:45 ET ArQule, Inc. and The R. W. Johnson Pharmaceutical Research Institute Add Compass Array(TM) Library to Collaboration Agreement   Sep 18, 00 17:31 ET EPIX Announces $45 Million Equity Financing Arrangement   08:31 ET Triangle Pharmaceuticals and Abbott Laboratories Report Drug Candidate DAPD Decreases Viral Load in Patients Infected With Resistant Virus When Added to Failing Drug Regimens   Sep 14, 00 13:20 ET SafeScience Announces Expanded Roster of Retail Outlets For Consumer Cleaning Products   10:08 ET Applied Molecular Evolution Signs Kauffman Licensing Agreement With Idexx For Diagnostic Development   06:59 ET Lexicon Genetics Obtains Affymetrix Technology to Accelerate Internal Drug Discovery Efforts   Sep 13, 00 16:35 ET Dyax Corp. Expands Antibody Discovery Capabilities   Sep 12, 00 08:36 ET Genomica Appoints Sean Ryan as Vice President of Sales   07:34 ET Genaissance Pharmaceuticals Reports First-Ever Link Between Gene Variants (Haplotypes) and Drug Response in the Proceedings of the National Academy of Sciences      Sep 11, 00 09:06 ET Keryx Reports Second Quarter 2000 Financial Results   07:30 ET Once-A-Day HAART Regimen Containing Coviracil(R)(Emtricitabine) Demonstrates Potent and Sustained Antiviral Activity Over 48-Weeks in HIV-Infected Patients   Sep 08, 00 09:54 ET Applied Molecular Evolution, Inc. Reports Financial Results for Second Quarter   Sep 07, 00 09:20 ET Promising Therapeutic Vaccine for Prostate Cancer Enters Expanded Clinical Studies   08:59 ET Anadys Pharmaceuticals Establishes Corporate Headquarters in San Diego And Appoints Key Senior Management Members   Sep 06, 00 10:33 ET ICAgen and Bristol-Myers Squibb Renew Drug Discovery And Development Collaboration   09:56 ET Lexicon Genetics Sublicenses Positive-Negative Selection Technology to Biogen   09:56 ET Paradigm Genetics Appoints Ellen T. Corliss Vice President of Corporate Communications   09:55 ET Aquila Biopharmaceuticals Receives Phase I SBIR Grant to Develop Lipid-based Vaccines for Staphylococcus aureus   Sep 01, 00 06:59 ET Ardais Corporation and Leading Medical Centers Launch Initiative to Accelerate Genomics-Based Drug Discovery   Aug 31, 00 09:36 ET Keryx Biopharmaceuticals, Inc. Announces Exercise of Over-Allotment Option   07:59 ET Intracel Analysis of Three OncoVAX(TM) Trials Extend Recurrence-Free Survival in Stage II Colon Cancer   Aug 29, 00 10:29 ET Viron Therapeutics Announces Preclinical Results on Novel Transplant Rejection Treatment   Aug 28, 00 08:37 ET Paradigm Genetics Awarded Phase II of $825,000 SBIR Grant For Gene Discovery Work   Aug 25, 00 08:52 ET ICAgen Honored as Third Fastest Growing Technology Company in North Carolina   Aug 23, 00 09:02 ET Published Study Provides Insight Into MARstem(TM) Mechanism for Hematopoiesis   08:59 ET Rene A. Braeckman, Ph.D. Joins Pan Pacific Pharmaceuticals, Inc.   06:59 ET Lexicon Genetics Formalizes Entry Into Japanese Drug Discovery Market   Aug 22, 00 16:37 ET Dyax Announces Exercise of Underwriters' Overallotment Option   Aug 21, 00 08:29 ET Paradigm Genetics, Inc. Exceeds by 20% Milestone Deliverables in Pharmacia Collaboration   Aug 17, 00 10:01 ET ArQule and Nanosyn Announce Microchemistry Technology Evaluation And Chemistry Services Agreement   09:23 ET ImmunoGen, Inc. Reports Year-End Financial Results   Aug 16, 00 08:59 ET ZymoGenetics Appoints Frank Collins, Ph.D. as Senior Vice President of Research   Aug 15, 00 08:46 ET Dyax Corp. Announces Pricing of Initial Public Offering   Aug 14, 00 18:29 ET SafeScience Reports Second Quarter 2000 Financial Results   08:29 ET Cambridge NeuroScience Reports Second Quarter 2000 Financial Results   08:05 ET Novelos and Phytera Agree to Develop and Commercialize Novel Cancer Drug   Aug 10, 00 08:59 ET Anadys Pharmaceuticals and Pharmacia Collaborate To Discover New Antifungal Drugs   07:31 ET Triangle Pharmaceuticals Announces the Continued Development of Coactinon (R) (Emivirine)   Aug 09, 00 11:04 ET NitroMed and Brigham and Women's Hospital Issued Broad U.S. Patent Covering NO-Coated Stent Technology   Aug 08, 00 09:53 ET HealthCite and AMGEN Announce Strategic Internet Alliance   05:59 ET ChiRex Reports Financial Results for Second-Quarter 2000   Aug 07, 00 08:59 ET Aquila Biopharmaceuticals Reports Financial Results For the Second Quarter of 2000   08:31 ET Mosaic Appoints Michael E. Furlong to Vice President of Business Development   Aug 03, 00 08:19 ET Hyseq Announces Second Quarter Results   Aug 02, 00 08:30 ET ICAgen Acquires Novel Ion Channel Gene Technology and Targets For Nervous System and Immunological Disorders   08:14 ET University of Nebraska Medical Center and Intracel Report Pilot Clinical Results with HumaRAD Fully Human Monoclonal Antibody-based Treatment of Head and Neck Cancer   06:59 ET Genaissance Pharmaceuticals, Inc. Announces Initial Public Offering of Common Stock      Aug 01, 00 13:30 ET Applied Molecular Evolution, Inc. Announces Exercise of Over-Allotment Option in Connection With Initial Public Offering   08:53 ET Paradigm Genetics Announces Second Quarter Financial Results   08:27 ET Hyseq Announces Markman Clarification in Litigation with Affymetrix   07:10 ET Lexicon Genetics and Arena Pharmaceuticals Target New Receptors for Pharmaceutical Development   Jul 31, 00 07:29 ET Triangle Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2000   Jul 28, 00 12:22 ET Genomica Wins Prestigious Innovation Award for Discovery Manager(TM) Software   09:29 ET Keryx Biopharmaceuticals, Inc. Announces Initial Public Offering   08:35 ET BioMarin Announces Second Quarter 2000 Financial Results   Jul 27, 00 09:27 ET Applied Molecular Evolution, Inc. Announces Pricing of Initial Public Offering   08:30 ET iSalvex.com Partners with Stoner & Company   07:31 ET ArQule Appoints New Vice President of Discovery Alliances   06:59 ET Lexicon Genetics Announces Second Quarter Financial Results   Jul 26, 00 08:28 ET Paradigm Genetics Reaches Gene Function Discovery Throughput of 150 Genes Per Week   Jul 25, 00 09:04 ET U.S. Patent Issued For RTP Pharma Innovative Technology   06:30 ET Lexicon Genetics Announces Functional Genomics Collaboration For The Discovery Of Novel Drug Targets For Schizophrenia   Jul 24, 00 09:02 ET Massachusetts Biotechnology Council Names Janice Bourque President and CEO   Jul 20, 00 18:31 ET EPIX Medical Reports Second Quarter 2000 Results   08:29 ET Paradigm Genetics Appoints Jeffrey R. Shuster Ph.D. to Director of Microbial Research   Jul 19, 00 18:12 ET EPIX Files Shelf Registration   07:45 ET ArQule, Inc. Reports Strong Financial Results for Second Quarter, 2000   Jul 18, 00 07:01 ET Triangle Pharmaceuticals, Inc. Appoints Robert Amundsen, Jr. as Chief Financial Officer and Andrew Finkle as General Counsel   Jul 17, 00 08:29 ET Ischemia Technologies Seeks FDA Clearance To Market Rapid Diagnostic Test For Chest Pain Patients   Jul 13, 00 17:00 ET EPIX Medical Promotes Pamela E. Carey to Vice President of Finance and Administration and Chief Financial Officer   08:31 ET ImmunoGen Joins Russell 3000(R) Index   Jul 12, 00 10:51 ET ChiRex Announces First License of Jacobsen Hydrolitic Kinetic Resolution Technology   08:55 ET Aquila's QS-21 Adjuvant Maintains Immune Response of HIV Vaccine at Low Antigen Doses   Jul 11, 00 08:31 ET Cambridge NeuroScience Obtains Exclusive Rights to Neuregulin-2 Growth Factor From Harvard University   08:31 ET Paradigm Genetics, Inc. Added to Russell 3000 Index   Jul 06, 00 08:01 ET Coley Pharmaceutical Group Expands Management Team   07:29 ET Lexicon Genetics and Howard Hughes Medical Institute Agree on Terms For Access to Knockout Mice   Jun 29, 00 09:02 ET Anadys Pharmaceuticals Inc. Established to Unite Pioneering Drug Discovery and Scientific Leaders From Scriptgen Pharmaceuticals, The European Molecular Biology Laboratory and The Scripps Research Institute   Jun 28, 00 15:36 ET Aquila Announces License Agreement With Beth Israel Deaconess Medical Center For Antibodies That Enhance Immune Function   06:34 ET Lexicon Genetics Announces Issuance of Key Gene Trapping Patent   Jun 27, 00 17:28 ET Genomica's Enhanced Discovery Manager(TM) Software Launched to Provide Critical Tools for Genomics Research   12:41 ET New Drug Works Well as Sole Epilepsy Therapy for Difficult-to-Treat Patients   12:38 ET New Study Demonstrates Safety, Efficacy and Tolerability of Oxcarbazepine as Adjunctive Therapy in Children with Uncontrolled Partial Seizures   08:24 ET Paradigm Genetics Applies Industrialized Gene Function Alteration To Two Major Fungal Pathogens   Jun 26, 00 16:05 ET LexVision(TM) Functional Genomics Program to Bring Meaning to the Genes in the Human Genome   08:29 ET NitroMed and the University of Texas at Austin Report Phase II Clinical Results of Potential Drug Therapy for Female Sexual Dysfunction   Jun 22, 00 12:05 ET Aquila Biopharmaceuticals Receives Phase I SBIR Grant to Develop Chlamydia Vaccine Using CD1 Technology   07:59 ET Coley Pharmaceutical Group Signs Collaboration With Ludwig Institute for Cancer Research   07:31 ET Lexicon Genetics Announces Expansion of Corporate Collaboration With Millennium Pharmaceuticals   Jun 21, 00 09:31 ET Novartis Announces Availability of First New Alzheimer's Disease Treatment in Over Three Years   Jun 20, 00 07:31 ET Lexicon Genetics Announces It Has Altered Over One-Third of the Genes in the Mouse Genome, an Important Milestone for Human Drug Discovery   Jun 19, 00 12:50 ET Genomica Licenses Discovery Manager(TM) Software to the National Institutes of Health's Craniofacial Epidemiology and Genetics Branch   Jun 15, 00 08:59 ET Michael Astrue Elected Chair of New MBC Directorate for 2000 - 2002   08:29 ET Paradigm Genetics, Inc. Reports First Quarter Financial Results   Jun 14, 00 18:39 ET Lexicon Genetics Reiterates Patent Infringement Claims Against Deltagen   Jun 13, 00 08:59 ET Domain Pharma Introduces Clintrial Connect(TM) for Electronic Clinical Trials   Jun 12, 00 06:31 ET Triangle Pharmaceuticals Presents Antiviral Activity of DAPD in HIV-Infected Patients with Multiple Drug Failure   06:30 ET Triangle Pharmaceuticals Reports Data From Phase I/II Study of a Protease Inhibitor, DMP-450 in HIV-Infected Patients   Jun 09, 00 05:30 ET Schering AG and EPIX Medical Establish Partnership For MRI Cardiovascular Contrast Agents   05:15 ET Schering AG Signed Agreements With EPIX Medical and Mallinckrodt to Develop and Market MS-325   Jun 08, 00 08:59 ET Genomica Appoints Charles W. Philipp as Vice President of Marketing   Jun 07, 00 11:51 ET NitroMed Reports Positive Preclinical Results with NO-Enhanced Anti-ulcerants   08:59 ET Maret Initiates Second Clinical Trial With MARstem(TM)   08:37 ET Mark Boguski Joins Rosetta Inpharmatics   Jun 06, 00 08:59 ET Reprogenesis Reports Preclinical Studies in PNAS on Tissue Engineered Product to Prevent (Re)stenosis   Jun 05, 00 14:35 ET SafeScience Announces Initiation of Phase II Trial for GBC-590 In Colorectal Carcinoma   14:16 ET Former Chairman and CEO of SafeScience Agrees Not to Sell Stock for Two Years   08:59 ET NitroMed Reports Positive Preclinical Results for Lead Female Sexual Dysfunction (FSD) Treatment Using Innovative Evaluation Technique   May 31, 00 09:29 ET Repair, Inc. Raises $2 Million Seed Financing to Develop Cardiovascular Disease Therapies with Drug Delivery and Angiogenesis Technologies   08:32 ET Paradigm Genetics, Inc. Announces Exercise Of Over-Allotment Option in Initial Public Offering   07:30 ET Lexicon Genetics' Knockout Technology Used To Develop First Animal Model for Canavan Disease   May 30, 00 08:59 ET ZymoGenetics Names George B. Rathmann, Ph.D. and Edward E. Penhoet, Ph.D. to Board of Directors   May 25, 00 14:00 ET PE Biosystems and Genomica Corporation Form Product Development and Reseller Alliance   May 24, 00 18:08 ET Lexicon Genetics Files Patent Infringement Suit Against Deltagen   08:48 ET Genaissance Appoints Paul Oestreicher, Ph.D. as Vice President, Public Affairs      08:23 ET Hyseq Names Dr. George B. Rathmann as President and CEO   May 23, 00 02:00 ET CeNeS Pharmaceuticals plc and Cambridge NeuroScience Inc. Agree to Merge   May 19, 00 14:28 ET Dyax Corp. Files Registration Statement for Proposed Initial Public Offering   12:54 ET The Medicines Company Files Registration Statement For Proposed Initial Public Offering   May 18, 00 08:29 ET BioMarin Appoints Robert A. Baffi, Ph.D., as Vice President Quality Assurance and Quality Control   08:29 ET Paradigm Genetics, Inc. Exceeds First Milestone in Monsanto Collaboration   May 17, 00 11:32 ET SafeScience Announces Issuance Of Foreign Patent For Modified Pectin Material For Treatment Of Cancer   10:01 ET Viron Therapeutics Announces Preclinical Results At American Society of Transplantation Meeting   08:56 ET The Medicines Company Receives Approvable Letter for ANGIOMAX(TM)   07:29 ET Hyseq Extends Cancer Gene Discovery Agreement With Chiron For Additional Two Years   May 16, 00 08:59 ET iSalvex.com Announces $4 Million in Series A Financing - Web-based exchange is unique solution to insurance salvage asset sales -   04:11 ET ImmunoGen, Inc. Appoints Mark Skaletsky of GelTex Pharmaceuticals, Inc. to Board of Directors   May 15, 00 08:45 ET Aquila Biopharmaceuticals Retains Financial Advisor To Evaluate Recent M&A Inquiries   May 12, 00 16:22 ET SafeScience Reports First Quarter 2000 Financial Results   09:19 ET Hyseq Surpasses Prior Biochip Sequencing Record   07:44 ET Hyseq Announces 5 kb Sequencing on the HyChip(TM)   May 11, 00 12:06 ET ACADIA Pharmaceuticals and ArQule Inc. Enter Licensing Agreement Covering Novel Serotonergic Lead Compounds   09:21 ET Paradigm Genetics Agreement With Monsanto Expanded to Include Renessen LLC   08:59 ET Therapeutic Prostate Cancer Vaccine Shows Promise in Early Clinical Study   May 10, 00 07:00 ET Lexicon Genetics Discovers Gene Controlling Onset Of Aging In Mice      06:30 ET CuraGen Receives Patent Covering High-Throughput Proteomics Technology   May 09, 00 12:23 ET EPIX European Patent Upheld   08:41 ET Scriptgen Appoints Devron R. Averett, Ph.D. to Senior Vice President of Research, Development, and Medical -Former Head of Molecular and Cellular Virology at Glaxo Wellcome to Lead Research and Development-   08:35 ET Cambridge NeuroScience Reports First Quarter 2000 Financial Results   02:01 ET EPIX Grants Patent License For Schering AG's Eovist   May 08, 00 08:29 ET BioMarin Announces Senior Management Changes   08:29 ET ImmunoGen and Genentech Form Multi-Product Collaboration to Develop Tumor-Activated Prodrugs   May 05, 00 15:05 ET Paradigm Genetics Announces Pricing of Initial Public Offering   08:29 ET ImmunoGen, Inc. and British Biotech plc Enter Collaboration to Develop and Commercialize huN901-DM1 for the Treatment of Small-Cell Lung Cancer   May 04, 00 08:32 ET ImmunoGen and Genentech Sign Exclusive License Agreement   May 03, 00 13:36 ET Aquila Biopharmaceuticals Announces Preliminary Results of Quilvax-M(TM) Mastitis Trial   11:35 ET SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 For Treatment of Pancreatic Cancer at University of Rochester Cancer Center   06:31 ET Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2000   May 01, 00 09:01 ET Coley Pharmaceutical Group Reports First Phase I/II Human Clinical Data   08:59 ET RecoveryCare.com and DePuy Orthopaedics Announce Strategic Alliance to Offer Web-Based Resource to Orthopaedic Surgeons   Apr 28, 00 08:29 ET BioMarin Announces First Quarter 2000 Financial Results   07:24 ET Lexicon Genetics Announces First Quarter Financial Results   Apr 27, 00 16:59 ET EPIX Medical Reports First Quarter 2000 Results   11:35 ET AutoImmune Inc. Reports First Quarter 2000 Financial Results   08:59 ET Quorum Sciences Receives Grant to Advance Novel Approach for the Treatment and Prevention of Cystic Fibrosis   Apr 24, 00 09:02 ET Novartis Receives FDA Marketing Clearance for New Alzheimer's Disease Treatment   08:45 ET Aquila Biopharmaceuticals Reports Financial Results For the First Quarter Of 2000   Apr 20, 00 15:41 ET ImmunoGen, Inc. Reports Third Quarter Financial Results   07:45 ET ArQule, Inc. Reports Improved Financial Results for First Quarter, 2000 and Announces Withdrawal of Follow-On Offering   Apr 19, 00 09:02 ET SafeScience Announces Phase II Trial For GBC-590 Expanded to University of Chicago Medical Center   08:59 ET Enmed Bolsters Management Team   06:03 ET Chirex Announces Share Repurchase Program   05:55 ET ChiRex Reports Financial Results for First-Quarter 2000   Apr 18, 00 08:59 ET Paradigm Genetics Delivers High Throughput Screening Assay to Bayer AG   08:29 ET Aronex Pharmaceuticals Completes $8.1 Million Private Placement   Apr 17, 00 11:08 ET Coley Pharmaceutical Group Initiates Phase I/II Clinical Trials Of CpG 7909 for Cancer   07:02 ET ChiRex and GlaxoWellcome Reshape 1997 Supply Agreement With Intent For Long-Term Strategic Partnership   Apr 14, 00 11:16 ET SafeScience Launches Chemically Safe Garden Product Line for Consumers   08:31 ET Lexicon Genetics Announces Issuance of Patent On Novel Cancer Target   Apr 13, 00 06:30 ET CuraGen and Genentech Extend Broad-based Drug Discovery Collaboration   Apr 12, 00 08:29 ET XTL's Trimera(XTL) System Subject of Presentation at International Symposium On Viral Hepatitis and Liver Disease   Apr 11, 00 15:31 ET SafeScience Announces Commencement of GBC-590 Phase II Trial   12:48 ET Yale University and Genaissance Co-Sponsor Conference on Pharmacogenetics Revolution   12:46 ET SafeScience, Inc. Receives IRB Approval for Phase II Studies of GBC-590 for Treatment of Pancreatic Cancer at Christiana Hospital   Apr 07, 00 11:40 ET Triangle Pharmaceuticals Announces Clinical Hold on Study FTC-302   Apr 06, 00 20:13 ET Lexicon Genetics Incorporated Announces Pricing of Initial Public Offering   17:21 ET Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With American Home Products   15:28 ET Lexicon Genetics Names C. Thomas Caskey, M.D. Chairman   10:58 ET Triangle Pharmaceuticals Announces Receipt of Letter From South Africa's Medicines Control Council Concerning Study FTC-302   09:15 ET BioTransplant Initiates Phase I/II Trial of AlloMune(TM) Cancer System   08:29 ET Collgard Biopharmaceuticals' Receives Patent for New in Class Cancer Treatment   08:29 ET SafeScience and Universal Environmental Technologies To Market Chemical-Free Scale Reduction and Water Treatment Systems   07:31 ET Triangle Pharmaceuticals Clarifies Report Out of South Africa   Apr 05, 00 08:59 ET David K. Stevenson Elected to the ChiRex Board of Directors   Apr 04, 00 15:31 ET SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 For Treatment of Pancreatic Cancer at Beth Israel Deaconess Medical Center   06:30 ET Triangle and Dynavax Enter Collaborative Agreement To Develop Immunotherapies For Hepatitis and HIV   Apr 03, 00 17:59 ET A. Gregory Sorensen, M.D., Joins Epix Medical, Inc.   15:16 ET AngioMARK Subject of Four Presentations at International MRI Conference   06:30 ET CuraGen and Gemini Enter Genome Wide Drug Target Discovery and Pharmacogenetics Collaboration   Mar 31, 00 11:05 ET SafeScience Reports 1999 Year End Financial Results   11:01 ET SafeScience, Inc. Completes $9 Million Private Placement With a Total Potential of $18 Million   Mar 30, 00 07:59 ET CuraGen and COR Therapeutics Expand Drug Discovery And Pharmacogenomics Collaboration   Mar 29, 00 07:59 ET RHeoGene to Report Key Progress in Gene-Switching Program at BIO 2000   Mar 28, 00 08:59 ET RTP Pharma Inc. Expands Business Development Team   07:59 ET - EPIX Medical, GE Medical Systems and Vital Images Discuss Innovations in the Diagnosis and Management of Vascular Disease -   Mar 27, 00 08:29 ET EPIX Agent Shows Promise in Mouse Model for Muscular Dystrophy   08:29 ET ICAgen and Yamanouchi Form Collaboration to Develop Novel Central Nervous System Therapeutics   08:29 ET Triangle Pharmaceuticals, Inc. Appoints Chris A. Rallis As President and Chief Operating Officer   07:31 ET Senator Kennedy and the Massachusetts Biotechnology Industry Promote Science Education at BIO 2000   Mar 24, 00 08:57 ET Aquila Closes Private Placement   Mar 22, 00 11:29 ET ICAgen and Children's Hospital Boston Collaborate to Identify And Develop Novel Pharmaceuticals   09:15 ET BioTransplant and The Massachusetts General Hospital Announce Award of U.S. Patent Covering a Novel Approach to Xenotransplantation Tolerance   Mar 21, 00 18:09 ET ArQule Appoints Two New Board Members   14:30 ET Dyax Signs Collaboration with Human Genome Sciences For Discovery of Human Therapeutics   09:01 ET Mosaic Appoints Vice President of Marketing   07:59 ET AutoImmune Inc. Signs Agreement   07:59 ET CuraGen to Apply Functional Genomic Technologies to Assemble Proteomic Map of Drosophila Genome   Mar 20, 00 10:20 ET equity4life: New Investment Company in the Healthcare Sector   08:29 ET EPIX MRI Contrast Agent Enables Highly Detailed Breast Cancer Images Using Cost Effective, Open MRI Scanners   07:29 ET Triangle Pharmaceuticals Announces a $15 Million Private Placement to Fund a New Health Information Technology Company, Intelligent Therapeutic Solutions, Inc.   Mar 17, 00 18:24 ET Rosetta Inpharmatics, Inc. Registers With SEC for Initial Public Offering   13:36 ET Rosetta Inpharmatics Inc. Names Gregory Sessler Chief Financial Officer   Mar 16, 00 08:29 ET ICAgen Appoints James Heyward Hull, Pharm.D., to Senior Vice President of Development and Regulatory Affairs   Mar 15, 00 08:31 ET Genomica Corporation Files for Initial Public Offering   Mar 14, 00 12:59 ET Genomica Appoints Kenneth S. Rubin Executive Vice President of Commercial Development   10:41 ET Genomica Corporation Raises $15 Million in Private Financing   10:40 ET Instrumentation Laboratory and InSource Health Services Solidify Partnership With Sole Source Agreement for Critical Care Systems   06:59 ET Genaissance Pharmaceuticals, Inc., Closes $60 Million Private Placement   Mar 13, 00 08:59 ET Patrick J. Sullivan, President and CEO of Cytyc Corporation, Joins Mosaic's Board of Directors   08:29 ET Coley Pharmaceutical Group Names Jerry A. Weisbach, Ph.D. and Manfred Karobath, M.D. to Board of Directors   Mar 10, 00 17:01 ET JSB Partners, LP Announces Its Advisory Role in Mitotix, Inc. Transaction   09:59 ET Collgard Biopharmaceuticals' Halofuginone Receives Orphan Drug Designation for Scleroderma from FDA   Mar 09, 00 07:59 ET Cardiac Science Announces Arizona Heart Hospital Is First Hospital To Purchase Powerheart(R)   Mar 08, 00 10:01 ET Scriptgen and 3DP Settle Patent Dispute   Mar 06, 00 09:46 ET Aquila Biopharmaceuticals' QS-21 Is Key Component in Several New Vaccines In the Clinic   07:29 ET Reprogenesis, Inc. Acquires Exclusive License to Children's Hospital/Harvard/MIT Organ Regeneration Technology and Product for Bladder Reconstruction   Mar 02, 00 08:29 ET Aastrom Biosciences Completes Private Equity Financing   07:59 ET CuraGen's Board of Directors Authorizes Two-for-One Stock Split   Feb 29, 00 12:02 ET Domain Pharma Corporation Announces Appointment of Graham Bunn as Global Vice President of Business Information Technology   12:02 ET Domain Pharma Corporation Announces Promotion Of Toby Bloom, Ph.D., To Chief Technology Officer   09:29 ET Bayer AG Selects Domain Pharma Corporation's Clintrace(TM) Release 2.8 For Adverse Event Tracking and Reporting   08:59 ET Genomica Corporation Unveils Latest Release of Its Discovery Manager(TM) Product at Genome Tri-Conference   Feb 28, 00 17:15 ET SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 for Treatment of Pancreatic Cancer   10:24 ET ACT Group, Inc. Acquires Key Assets of Advanced Cell Technology, CIMA Biotechnology and Cyagra   08:59 ET ACT Group, Inc. Acquires Key Assets of Advanced Cell Technology, CIMA Biotechnology and Cyagra   Feb 25, 00 07:31 ET Triangle Pharmaceuticals, Inc. Reports Financial Results For Fourth Quarter And Year Ended December 31, 1999   Feb 24, 00 17:00 ET EPIX Medical Reports Fourth Quarter and Year-End Results For 1999   16:12 ET SCS Comments Relating to EPO Grant of 'Stem Cell Selection' Patent   10:21 ET TechEx Creates Internet Platform With Harvard and Its Affiliate Hospitals For Corporate Access to Biomedical Resources   08:29 ET AutoImmune Inc. Reports 1999 Fourth Quarter and Year End Financial Results   08:29 ET ImmunoGen Enters Research Collaboration With SUNY Stony Brook To Develop Taxane-Based Tumor-Activated Prodrugs   Feb 23, 00 08:46 ET Paradigm Genetics Reaches Bayer AG Collaboration Milestones   08:31 ET Kinetix Pharmaceuticals and Dana-Farber Cancer Institute   08:29 ET Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With Boehringer Ingelheim   Feb 22, 00 12:40 ET Paradigm Genetics Files Registration Statement for Proposed Initial Public Offering   09:05 ET Past CEO of Rhone-Poulenc Rorer Joins CuraGen's Board of Directors   08:41 ET ValiGene and Kimeragen In Merger to Create ValiGen, An Integrated Functional Genomics Company   08:29 ET Aquila Biopharmaceuticals Reports Financial Results for 1999   Feb 18, 00 13:15 ET Triangle Pharmaceuticals Announces Management Change   08:29 ET BioMarin Announces Fourth Quarter and 1999 Financial Results   Feb 17, 00 11:05 ET Aastrom Biosciences, Inc. Denies Fallacious Press Release   Feb 16, 00 10:51 ET Avant Immunotherapeutics Showcases Lead Product at Major Biotech Industry Conference   10:15 ET EPIX Medical Presents at BIO CEO & Investor Conference - AngioMARK, Lead Contrast Agent for MRI, in Late Stage Trials -   09:15 ET ImmunoGen, Inc. Provides Corporate and Clinical Update at 2nd Annual BIO CEO & Investor Conference   08:53 ET Coley Pharmaceutical Group Presenting at 2nd Annual BIO CEO & Investor Conference   08:29 ET BioMarin Pharmaceutical to Present at BIO CEO & Investor Conference   08:29 ET Lexicon Genetics Names James R. Piggott, Ph.D. Senior Vice President of Pharmaceutical Biology   08:29 ET XTL Biopharmaceuticals Reports First Human Data on Combination Monoclonal Antibody Therapeutic for Hepatitis B   08:01 ET StressGen to Present at 2nd Annual BIO CEO & Investor Conference   07:45 ET ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended 1999   Feb 15, 00 08:29 ET Hyseq Awarded Patent Covering Use of Electrical Fields on Biochips   Feb 14, 00 16:01 ET MetaPhore to Exhibit Scientific Highlights at BIO CEO Conference   09:29 ET BioTransplant Incorporated Reports 1999 Fourth Quarter and Year End Results   09:15 ET BioTransplant Incorporated Completes $9.7 Million Private Placement   08:50 ET CuraGen Completes $150 Million Convertible Debentures Offering   08:29 ET Aquila Biopharmaceuticals Receives License Payments From Partners   08:29 ET Lexicon Genetics Names Julia P. Gregory Executive Vice President and Chief Financial Officer   08:29 ET Therion and National Cancer Institute Extend Collaborations   Feb 11, 00 08:00 ET UroGen Receives FDA Clearance to Enter Human Clinical Trial Of Gene Therapy for Hemophilia A   07:45 ET ArQule Appoints New Chief Financial Officer and Director of Business Development   Feb 10, 00 06:59 ET CuraGen Completes First Functional Genomics Map of Entire Genome   Feb 09, 00 15:06 ET Lexicon Genetics Incorporated Files Registration Statement for Proposed Initial Public Offering   Feb 08, 00 10:54 ET Biolink Raises $15.6 Million in Private Financing   08:29 ET Aastrom Biosciences, Inc. Reports Second Quarter Financial Results   06:31 ET ChiRex Reports Financial Results For Fourth-Quarter and Full-Year 1999   Feb 07, 00 13:34 ET Cambridge NeuroScience Reports Fourth Quarter and Year-End 1999 Financial Results   Feb 04, 00 08:00 ET Rosetta Inpharmatics Publishes Breakthrough Approach to Link Genomics To Protein Function in Science   Feb 03, 00 09:05 ET Hyseq Announces Financial Results for the Fourth Quarter and Year Ended December 31, 1999   08:31 ET Argonex and Wyeth-Lederle Enter Research Collaboration   08:30 ET Lexicon Genetics Announces Omnibank(R) Internet Universal(TM) Agreement With Organon   08:30 ET Phytera Completes $9.1 Million Financing   Feb 02, 00 14:52 ET Biolink Raises $15.6 Million in Private Financing   07:59 ET Dr. George B. Rathmann Joins Hyseq as Chairman   07:29 ET Triangle Pharmaceuticals Reports First Human Data From Phase I/II Study Of DAPD in HIV-Infected Patients   Feb 01, 00 07:29 ET Once-A-Day Haart Regimen Containing Coviracil(R) (Emtricitabine) Shows Potent Antiviral Activity In HIV-Infected Patients   Jan 31, 00 12:05 ET SafeScience Appoints John W. Burns as Chief Financial Officer   09:15 ET Massachusetts General Hospital and BioTransplant Incorporated Report Advances in Organ Transplantation and Immunocompetency   08:29 ET Phytera and Unilever Sign Joint Research and Development Agreement   Jan 28, 00 12:49 ET Biolink Names Donald H. Woods Senior Vice President   08:45 ET CuraGen Raises $125 Million from the Sale of Convertible Debentures   Jan 27, 00 08:29 ET Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With The R.W. Johnson Pharmaceutical Research Institute   Jan 26, 00 15:35 ET FDA Approves the Commercial Version of Cardiac Science's Powerheart(R) ECD(TM)   Jan 25, 00 08:29 ET Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With Searle   Jan 24, 00 09:02 ET Paradigm Genetics Enters Into Collaboration Agreement For Gene Function Research   08:29 ET The Medicines Company Acquires Innovative OB/GYN Product   Jan 20, 00 21:17 ET CuraGen Announces Proposed Sale of $100 Million of Convertible Notes   21:11 ET CuraGen Announces Fourth Quarter and Year End 1999 Financial Results   13:05 ET Lexicon Genetics Announces Launch of Lexgen.com(TM) Genomics Internet Exchange   Jan 19, 00 09:02 ET Afferon Corporation Advances U.S. Clinical Trial Program for Lead Product to Treat Urge Incontinence   08:29 ET ImmunoGen, Inc. Reports Second Quarter Results   08:29 ET MedLecture.com Debuts With User Base of 37,000+ Doctors; Pioneering e-Learning Tool Helps Time-Strapped Physicians   08:01 ET Coley Pharmaceutical Group and SmithKline Beecham Sign Collaboration   07:59 ET CuraGen Announces Change in Board of Directors   Jan 18, 00 08:59 ET Domain Pharma Announces Availability of Clintrial 4(TM) Release 4.2J for the Japanese Pharmaceutical Industry   08:29 ET Aquila Biopharmaceuticals Grants QS-21 License to Elan   08:29 ET Lexicon Genetics Grants Sublicense to Roche Bioscience Under Positive-Negative Selection and Isogenic DNA Technology   Jan 17, 00 11:44 ET FDA Grants Marketing Clearance for First New First-Line Monotherapy For Epilepsy (Seizure Disorder) in Six Years   11:43 ET FDA Grants Marketing Clearance for a New Treatment for Epilepsy (Seizure Disorder)   Jan 13, 00 11:59 ET AVANT Immunotherapeutics Is Leading a New Generation of Drugs In Cardiac Surgery   08:59 ET CpG ImmunoPharmaceuticals Changes Name to Coley Pharmaceutical Group   08:29 ET Lexicon Genetics Delivers 14 Lines of OmniBank(R) Mice to the Jackson Laboratory Under Contract With Merck Genome Research Institute   Jan 12, 00 11:32 ET CuraGen Receives Patents on Protein Interactions Implicated in Cancer   09:06 ET AltaRex In-Licenses Additional Antibody for AIT(R) Portfolio, Adds Leading Cancer Researchers to Scientific Advisory Board   07:45 ET Monsanto Extends and Expands Agreement with ArQule   Jan 11, 00 11:59 ET EPIX Medical, Inc. Speaks at Hambrecht & Quist 18th Annual Healthcare Conference   Jan 06, 00 11:43 ET Lexicon Genetics Announces Gene Function Collaboration With The Scripps Research Institute   Jan 05, 00 12:21 ET Aquila Initiates Third, Parallel Pivotal Product Licensing Study of Quilvax-M(TM)   10:31 ET WRPC Announces Glove Contract Will Not Be Renewed   08:31 ET Robert E. Petersen Returns to Publishing With Completion of Purchase of Sports Afield Magazine   08:31 ET license and development agreement with HeartSine Technologies, Inc. to utilize HeartSine's biphasic defibrillation waveform technology in Cardiac Science's in-hospital defibrillation products. In July 1999 Cardiac Science terminated its agreement in princ   Jan 04, 00 18:13 ET Cambridge NeuroScience and Algos Pharmaceutical Establish Licensing Agreement For Pain Products   09:00 ET AltaRex Announces Important Milestones for OvaRex(TM) MAb   08:29 ET Aquila Announces Issue of U.S. Patent Covering Isolation of Tick Borne Pathogen   08:29 ET CNA Announces Long-Term Care Industry's First 10-Year Rate Guarantee   Jan 03, 00 09:15 ET BioTransplant and The Massachusetts General Hospital Announce Award of U.S. Patent Covering a Unique Approach to Transplantation and Blood Cell Cancers   08:29 ET Cardiac Science Announces the First Commercial Shipment Of Powerheart(R) Hospital Defibrillator   Dec 29, 99 09:15 ET BioTransplant Incorporated Completes $7.7 Million Private Placement   Dec 23, 99 16:16 ET Genaissance Announces HAP(TM) Typing Facility For Processing of Clinical Trial Samples   Dec 21, 99 17:05 ET SafeScience Announces Issuance of Patent for Elexa Plant Defense Booster   09:01 ET International Isotopes Inc Announces Addition Of Bryce Drake and Scott Colpitts to Management Team   Dec 20, 99 10:42 ET Control Delivery Systems Announces Strengthened Management Team and Board of Directors   09:15 ET Domain Pharma Corporation Announces Availability Of Clintrace(TM) Release 2.8   08:29 ET Rosetta Inpharmatics Announces DuPont Pharmaceuticals as First Early Access Partner For Rosetta's Resolver(TM) Informatics System   Dec 16, 99 08:31 ET Genaissance Promotes Richard Judson, Ph.D. To Vice President Of Informatics And Appoints Martin Schultz, Ph.D. To Scientific Advisory Board   Dec 14, 99 08:29 ET Cambridge NeuroScience Receives Two U.S. Patents And Three U.S. Patent Allowances   Dec 10, 99 06:29 ET Triangle Pharmaceuticals Announces That Additional Phase III Studies for Coactinon(R) (Emivirine) Are Required   Dec 09, 99 12:45 ET huC242-DM1/SB-408075 Enters Phase I Human Clinical Studies   08:59 ET International Isotopes Inc Announces Additional Management Change   Dec 08, 99 07:59 ET TerraGen and Diversa Enter Into Patent Cross-Licensing Agreement   Dec 07, 99 14:24 ET AltaRex Publishes Early Prospective OvaRex(TM) MAb Data in the Journal Blood And Announces Updated Results   09:15 ET Massachusetts General Hospital and BioTransplant Present Advances In Transplantation Research at American Society of Hematology Conference   08:29 ET Aastrom Biosciences Receives Core Patent For Cell Therapy System   08:29 ET Argonex Completes $9.6 Million Financing to Expand Antigen Discovery Programs, Advance Clinical Programs   08:29 ET UroGenesys Researchers Discover New Target Antigen for Prostate Cancer   07:59 ET Published Study Concludes Unique Hospital Monitor Is Effective in Automatically Defibrillating Patients Within Seconds of Life-Threatening Heart Rhythms   Dec 06, 99 08:31 ET Cambridge Neuroscience Announces Extension of Allergan Collaboration   08:30 ET Therion Appoints Former Wyeth-Lederle Vaccines President, Ronald J. Saldarini, Ph.D., to Board of Directors   06:01 ET ChiRex Announces Shortfall in 2000 Demand From GlaxoWellcome Resulting In the Need to Rephase Supply Under the 1997 Agreement   Dec 03, 99 18:05 ET International Isotopes Inc Announces Management Changes   08:29 ET Lexicon Genetics Announces Agreement For Knockout Mice With BASF Bioresearch Corporation   Dec 02, 99 08:59 ET Maret Initiates Clinical Development Program With Lead Peptide for Chemotherapy Induced Neutropenia   Dec 01, 99 08:59 ET MetaPhore Receives Two SBIR Grants to Further Studies of Metal-Related Therapeutics   Nov 30, 99 15:45 ET International Isotopes Inc Obtains State Approval for Increased Production Of Medical Radioisotopes   08:31 ET ICAgen Raises $19 Million to Advance Ion Channel Drug Discovery and Development Programs   08:29 ET Aastrom Biosciences Announces Clinical Progress For The AastromReplicell(TM) System   07:59 ET Domain Pharma Corporation and Integrated Clinical Systems, Inc. Announce Availability of a Web Enabled Version of Integrated Review in December 1999   06:59 ET New Technique Tracks Female Sexual Response With Precision, EPIX Medical and Pfizer Data Show   Nov 29, 99 08:31 ET Cambridge NeuroScience Receives Two U.S. Patent Allowances For Key Growth Factor   08:29 ET AutoImmune Inc. Provides Update On Corporate Activities   08:29 ET Therion Awarded AIDS Vaccine Manufacturing Contracts from NIH   Nov 24, 99 12:22 ET SafeScience.com Internet Site Provides Communications Safety Net   Nov 23, 99 08:59 ET SafeScience Appoints Louis J. Riceberg, Ph.D. as Senior Vice President, Strategic Development and Kenneth J. Smaha as Chief Operating Officer   Nov 22, 99 12:26 ET MediSpectra Appoints Ross F. Flewelling, Ph.D., as Chief Technical Officer   09:01 ET New Data Demonstrate Activities of Daily Living Are Enhanced in Patients With Mild to Moderately Severe Alzheimer's Disease With Rivastigmine Tartrate   08:29 ET Cardiac Science Completes $8.7 Million Financing   Nov 19, 99 15:15 ET SafeScience Contracts Covance Inc. to Manage Phase II Trials of GBC-590 in Multiple Cancer Indications   Nov 18, 99 16:31 ET ImmunoGen Announces Data on Two New Tumor Types for huC242-DM1/SB-408075   08:31 ET AltaRex Announces Financial Results for the Third Quarter Ended September 30, 1999   08:31 ET Lexicon Genetics Grants Positive-Negative Selection Sublicense to Ligand Pharmaceuticals   Nov 17, 99 17:15 ET ImmunoGen Reports Anti-Tumor Activity and Minimal Toxicity for Small Cell Lung Cancer Compound   08:29 ET Aastrom Biosciences Awarded NIH Grant for Production Of T-Lymphocytes to Treat Viral Infections   08:29 ET Therion Appoints Richard Woodrich as Senior Vice President, Business Development   08:29 ET XTL Biopharmaceuticals and Roche Enter Agreement to Evaluate Therapeutics for Hepatitis C   Nov 15, 99 19:15 ET International Isotopes Inc Reports Third Quarter 1999 Financial Results   17:01 ET EPIX Medical, Inc. Exercises Loan Provision With Mallinckrodt, Inc.   11:41 ET Domain Pharma Corporation Receives ISO 9001 Certification   Nov 11, 99 13:03 ET MediSpectra Announces Key Advance in the Early Detection of Cervical Neoplasia   Nov 10, 99 08:59 ET ImmunoGen Options Antibody from Duke and Johns Hopkins Universities for Potential Development as Novel Cancer Therapeutic   Nov 09, 99 17:34 ET Pentose Demonstrates Utility of INACTINE(TM) For Viral Inactivation of Red Blood Cells and Plasma Transfusion Products   09:29 ET Children's Hospital, Boston and Boston Life Sciences Report Extensive Axonal Regeneration in Major Spinal Cord Pathway After Injury   09:15 ET BioTransplant Incorporated Reports Third Quarter 1999 Results   08:59 ET International Isotopes Inc Appoints Dr. David M. Camp As Chief Executive Officer   08:29 ET WRP Corporation Reports Third Quarter 1999 Results   Nov 08, 99 10:10 ET SafeScience Announces Global Strategy With Daymon Associates   08:59 ET -- Genaissance Awarded Broad Patent on Methods For Collecting Genes For Variation Analysis Across Populations --   Nov 05, 99 08:31 ET Cardiac Science Launches Unique Hospital Defibrillator At American Heart Association 72nd Scientific Sessions   08:30 ET LeukoSite Reports Third Quarter 1999 Financial Results   08:15 ET Inaugural Southeastern BIO Investor Forum to Highlight Over 20 Life Science Companies to Investors   Nov 04, 99 12:49 ET SafeScience Reports 1999 Third Quarter Financial Results   10:51 ET Domain Pharma Announces Launch Date For New Web-Based Remote Data Capture Solution For Internet Clinical Trials in Mid-2000   10:32 ET Mosaic Promotes Chris Boles, Ph.D. to Vice President of Research   Nov 02, 99 16:29 ET EPIX Medical Promotes Stephen C. Knight, M.D. to President and COO   08:59 ET XTL Biopharmaceuticals Establishes U.S. Operations   08:29 ET AutoImmune Inc. Reports Third Quarter 1999 Results   Nov 01, 99 17:37 ET Cardiac Science Announces Third Quarter Results   16:06 ET New EPIX Agent Provides High Resolution Images of Blood Clots   08:29 ET BioMarin Announces Third Quarter 1999 Financial Results   07:59 ET CuraGen Announces Second GeneCalling(TM) Gene Expression Patent   Oct 28, 99 12:00 ET Domain Pharma Corporation Expands Collaboration With Integrated Safety Systems, Inc.   08:29 ET Investigational Anticoagulant ANGIOMAX(TM) (formerly Hirulog(R) (bivalirudin)) To Be Made Available Through Expanded Access Study   07:59 ET CuraGen Announces Third Quarter 1999 Financial Results   Oct 27, 99 11:47 ET TechEx and Aurigin Systems Agree to Collaborate   08:29 ET Cambridge NeuroScience Reports Third Quarter 1999 Financial Results   08:29 ET Pentose Receives SBIR Grant for INACTINE(TM) Red Blood Cell Viral Inactivation Technology   Oct 26, 99 08:29 ET CpG ImmunoPharmaceuticals Appoints Aileen Ryan Vice President of Regulatory Affairs   07:01 ET Triangle Pharmaceuticals Presents Data From Pivotal Study Of Coactinon(R) (Emivirine) In Treatment-Naive, HIV-Infected Patients - Data Presented at 7th European Conference on Clinical Aspects And Treatments of HIV Infection in Lisbon -   06:59 ET Triangle Pharmaceuticals, Inc. Reports Financial Results For Third Quarter 1999   Oct 25, 99 10:21 ET ImmunoGen, Inc. Reports First Quarter Financial Results   10:14 ET Mitotix Announces Three U.S. Patents on p16 Tumor Suppressor Gene - Patented Technology Has Led to Preclinical Programs in Cancer, Cardiovascular Disease- CAMBRIDGE, Mass., Oct. 25 /PRNewswire/ -- Mitotix, Inc. announced today that the U.S. Patent and Tra   09:15 ET Massachusetts General Hospital and BioTransplant Report Research Advances for Cross-Species Transplantation   08:31 ET The Medicines Company's ANGIOMAX(TM) Brand of bivalirudin (formerly Hirulog(R)) Receives First Marketing Approval   08:29 ET Dyax Corp. and Pasteur Merieux Connaught Establish Collaboration   Oct 22, 99 15:23 ET Genaissance Announces Discovery of Extensive Gene Variation in Key Drug Targets   11:29 ET AltaRex Announces Operational Changes to Focus Support On Bringing OvaRex(TM) MAb to Market   09:00 ET International Isotopes Inc Announces Agreement With NeoRx Corporation   Oct 21, 99 18:25 ET Aquila Biopharmaceuticals Reports Financial Results For The Third Quarter 1999   16:55 ET EPIX Medical Reports Third Quarter 1999 Results   08:29 ET Aastrom Biosciences Reports Financial Results For its First Fiscal Quarter   Oct 19, 99 08:59 ET ICAgen Acquires Ion Channel Technology from Axys Pharmaceuticals   08:02 ET CuraGen Corporation Raises $26 Million from Biogen and Genentech   07:46 ET ChiRex Reports Financial Results for Third-Quarter and Nine-Months 1999; ChiRex Announces Agreement with Sepracor to Produce Three Products at Annan 3   06:38 ET /K I L L -- K I L L -- K I L L -- ChiRex Inc./   06:01 ET ChiRex Reports Financial Results For Third-Quarter and Nine-Months 1999   Oct 18, 99 09:50 ET European Patent Office Affirms Validity of Claims in Aquila's European Patent Covering Stimulon(R) Technology   08:29 ET Aquila Initiates Second, Parallel Pivotal Product Licensing Study of Quilvax-M(TM)   08:01 ET ArQule, Inc. Reports Financial Results For Third Quarter and Nine Months Ended September 30, 1999   07:59 ET Therion Biologics and National Cancer Institute Initiate Phase II Trial of Novel Melanoma Vaccines   Oct 15, 99 11:14 ET Market Value of New England-Based Biotechnology Industry More Than Doubles in Past 12 Months   Oct 14, 99 18:03 ET AltaRex Announces New Partnering Plans for OvaRex(TM) MAb : Purdue Foregoes Option   10:22 ET ImmunoGen Reports Favorable Pharmacokinetics for huC242-DM1/SB-408075   08:32 ET Instrumentation Laboratory Announces Agreement With Health Services Corporation of America   Oct 13, 99 08:59 ET Research Facilities Select Domain Pharma's Clintrial 4(TM) to Manage Clinical Trial Data   08:59 ET Rhone-Poulenc Agro and ICAgen Initiate Chemistry and Screening Agreement   Oct 12, 99 17:17 ET Reprogenesis, Inc. Awarded $2 Million Federal Grant For Cardiovascular Biology Program   10:20 ET International Isotopes Inc Initiates Dual Production of Heart Diagnostic   07:59 ET CuraGen Appoints Christopher K. McLeod as Executive Vice President   Oct 07, 99 17:20 ET Triangle Pharmaceuticals Announces Modification of its Clinical Study MKC-303   13:59 ET MetaPhore Reports on Stable SuperOxide Dismutase Mimetic with Activity Against Inflammation and Reperfusion Injury   07:59 ET CuraGen Appoints Peter T. Lomedico, Ph.D. as Vice President of Discovery Research   Oct 06, 99 08:29 ET Gemin X Presents Discovery of Novel Bcl-2 Inhibitor as Anticancer Agent At Conference on Differentiation Therapy   Oct 05, 99 16:01 ET Lexicon Genetics Announces Database Agreement With Millennium Pharmaceuticals   08:29 ET Aastrom Biosciences Retains Salomon Smith Barney For Merger and Acquisition Services   08:29 ET Dyax Signs 40th Licensee for Broad Phage Display Licensing Program   Oct 04, 99 08:02 ET CuraGen and Glaxo Wellcome Collaborate in Alzheimer's Disease Research   Oct 01, 99 07:29 ET ArQule and Bayer Announce Collaboration in Combinatorial Chemistry   Sep 30, 99 11:08 ET Domain Pharma Announces Appointment of Jennifer Cotteleer as Vice President, Consulting and Educational Services for North America   Sep 29, 99 15:30 ET ChiRex Appoints Professor Andrew G. Myers to Its Scientific Advisory Board   14:42 ET Inaugural Mass Opportunities Conference to Highlight 58 Biotechnology Companies to Investors   08:29 ET Aronex Pharmaceuticals Reports Phase II Data on NYOTRAN(R) in Patients With Systemic Fungal Disease at ICAAC   Sep 28, 99 08:31 ET Dyax Names Stephen Galliker, C.P.A. as Executive Vice President, Finance and Administration and Chief Financial Officer   08:31 ET XTL Biopharmaceuticals' Human Monoclonal Antibody Therapeutic For Chronic Hepatitis B Enters Phase I Clinical Trials   Sep 27, 99 13:00 ET ImmunoGen, Inc. Elects to Exercise $2.5 Million Put Option Under SmithKline Beecham Agreement   09:42 ET Novartis Receives FDA Approvable Letter For a New Therapy to Treat Epilepsy (Seizure Disorder)   09:25 ET Triangle Pharmaceuticals Reports Coactinon(R) (Emivirine) Phase II Study Demonstrates Potency and Tolerability in HIV-Infected Patients   09:25 ET Triangle Pharmaceuticals Reports Preliminary Resistance Profile Data On Coactinon(R) (Emivirine) in HIV Coactive Therapy   09:15 ET BioTransplant Achieves Milestone in Novartis Collaboration on Xenotransplantation   08:25 ET Aronex Pharmaceuticals Reports Phase III Data on Nyotran(R) in Patients With Systemic Fungal Disease at ICAAC   07:29 ET Triangle Pharmaceuticals Reports DAPD Preclinical Safety And Antiviral Activity Against Drug-Resistant HIV Strains   07:29 ET Triangle Pharmaceuticals Reports Data on Pharmacokinetics and Tolerability of Coactinon(R) (Emivirine) in HIV-1 Infected Pregnant Women and Their Offspring   Sep 24, 99 18:15 ET Aronex Pharmaceuticals Receives FDA Letter Concerning ATRAGEN   Sep 23, 99 13:11 ET MediSpectra Completes $10 Million Private Placement   Sep 21, 99 15:39 ET Inaugural Mass Opportunities Conference to Highlight 58 Biotechnology Companies to Investors   10:09 ET CuraGen Expands Database of Novel Human Genes to Over 70,000 Assemblies   09:05 ET ImmunoGen, Inc. Investigational New Drug Application for huC242-DM1/SB-408075 Accepted by FDA   08:29 ET Siemens Medical Systems, EPIX Medical, Mallinckrodt Collaborate on Magnetic Resonance Imaging Technology   Sep 20, 99 15:03 ET Novartis Launches New Alzheimer's Disease Website   08:29 ET Genaissance Appoints Dr. Jurgen Drews, Former President of Roche Global Research, as Board Chairman   Sep 17, 99 08:35 ET Aronex Pharmaceuticals Announces NYOTRAN(R) Phase III Data Accepted as Late Breaker Abstract at ICAAC   Sep 16, 99 09:31 ET Biolink Corporation Reports on Commercialization Advances In Europe for the Dialock(R) Hemodialysis System   Sep 15, 99 10:59 ET Reprogenesis, Inc. Closes $10.5 Million Financing   10:11 ET New Chemical Entities, Inc. and Thetagen, Inc. Merge   09:48 ET Instrumentation Laboratory Announces Agreement With InSource Health   Sep 14, 99 08:29 ET BioMarin and Genzyme Report Positive One Year Summary Data for MPS-1 Patients Receiving Enzyme Replacement Therapy   Sep 13, 99 17:41 ET Instrumentation Laboratory Announces Fiscal 1999 First Quarter Results   11:01 ET Shaw's, Safescience in Exclusive Co-Branding Agreement; Own Label Program Expanded With Tested Cleaning Products   08:31 ET XTL Biopharmaceuticals and Eli Lilly & Company Enter Agreement To Evaluate Therapeutics For Hepatitis C   07:59 ET WRP Corporation Named 'Top 100 Supplier' by Sysco Corporation For Fourth Consecutive Year   Sep 10, 99 10:08 ET NitroMed Acquires BiDil(TM) New Drug Application for Treatment Of Congestive Heart Failure   08:29 ET Dyax Promotes Pamela Hay to Senior Vice President of Corporate Development   Sep 08, 99 15:29 ET EPIX Medical Awarded U.S. Patent For Manufacturing Process   08:59 ET International Isotopes Obtains Regulatory Approvals From the State of Texas   08:29 ET CuraGen Completes $15 Million Private Financial Placement   Sep 07, 99 13:00 ET SafeScience, Inc. Clarifies Misinformation   Sep 03, 99 11:00 ET AltaRex and Biomira Announce Settlement of Lawsuits   Sep 02, 99 08:59 ET Cardiac Science Announces Distributors Ready for Global Launch of Unique Hospital Defibrillator   08:31 ET Lexicon Genetics Grants Sublicense to Avatar BioSci, Inc. For Infectious Disease and Cancer Applications   Sep 01, 99 07:30 ET AutoImmune Announces Phase III Trial Results for Colloral(R)   Aug 31, 99 12:14 ET TechEx Continues Rapid Growth and Expansion   08:29 ET Advanced Cell Technology Receives Broad U.S. Patent Covering Method of Nuclear Transfer for Non-Human Mammalian Cloning   08:29 ET BioMarin Announces Exercise of Underwriters' Over-allotment Option in Its Initial Public Offering   Aug 26, 99 10:37 ET Cardiac Science Announces Second Quarter Results   07:59 ET Amersham Pharmacia Biotech and Dyax Corp. Agree to Develop and Market Innovative Separations Technology   Aug 25, 99 08:09 ET Asthma Study Reveals Treatment Concerns Patients Skip Medication to Avoid Side Effects   Aug 24, 99 18:17 ET Double Transplant Frees Patient From Need for Immunosuppressive Drugs Patient Treated Successfully for Both Kidney Failure and Multiple Myeloma   08:59 ET Afferon Corporation Announces Two Appointments to its Board of Directors   Aug 19, 99 17:26 ET International Isotopes Inc Announces Second Quarter Financial Results   08:29 ET Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal Year 1999 Financial Results   Aug 18, 99 10:10 ET Stem Cell Sciences Announces Collaboration with Rhone-Poulenc Rorer   Aug 17, 99 16:29 ET BioMarin Announces Second Quarter 1999 Financial Results   08:29 ET Lexicon Genetics Announces Agreement for Knockout Mice With Rockefeller University   Aug 16, 99 08:31 ET Pentose Files Investigational New Drug Application for Red Blood Cell Viral Inactivation Technology   08:01 ET CuraGen Discovery Expands Database to Over 120,000 cSNPs   Aug 13, 99 08:59 ET WRP Corporation Reports Second Quarter 1999 Results   08:45 ET SafeScience Reports 1999 Second Quarter Financial Results   07:30 ET Triangle Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 1999   Aug 12, 99 17:55 ET LeukoSite Reports Second Quarter 1999 Financial Results   08:59 ET OXiGENE Exercises Option and Signs a Licensing Agreement For the Ombretastatin Technology From Arizona State University   08:32 ET AltaRex Announces Financial Results for the Second Quarter Ended June 30, 1999   08:29 ET -- Solvay's Worldwide Head of R&D to Join ArQule's Board of Directors --   Aug 10, 99 17:39 ET Aquila Biopharmaceuticals Receives Phase II SBIR Grant to Develop Tuberculosis Vaccine Using CD1 Technology   Aug 09, 99 10:22 ET Biolink Corporation Appoints Robert Mercier President and CEO and Expands Management Team   08:59 ET Argonex and Rohm and Haas Form Joint Venture   08:30 ET BioTransplant Incorporated Reports Second Quarter 1999 Results   Aug 06, 99 08:52 ET WRP Majority Shareholder Withdraws Verbal Merger Proposal at This Time   Aug 04, 99 09:18 ET SafeScience and Prince Agri Products Announce Product Development and Marketing Partnership   08:31 ET BioMarin Announces the Appointment of John L. Jost, Ph.D. as Vice President Manufacturing   08:29 ET Dyax Corp. Acquires Target Quest   Aug 03, 99 09:01 ET ICAgen and Bristol-Myers Squibb Extend Drug Discovery and Development Collaboration   08:32 ET Canadian Researchers Discover Gene Responsible For Regulation of HDL Cholesterol Levels   08:31 ET CpG ImmunoPharmaceuticals Completes $12.9 Million Financing   08:15 ET AutoImmune Inc. Reports Second Quarter 1999 Results   Aug 02, 99 08:29 ET - ArQule Appoints Dr. Philippe Bey, Formerly of Hoechst Marion Roussel (HMR), as New Chief Scientific Officer, Senior VP Research -   08:29 ET UCB Pharma Appoints Thomas Beck, M.D. as President and Director of Global Research   08:29 ET VARIAGENICS, INC. Closes $19.0 Million Financing, Taylor J. Crouch Appointed as President and CEO   Jul 29, 99 08:30 ET Instrumentation Laboratory and Beckman Coulter Announce New Strategic Alliance and Cross Distribution Agreement   08:15 ET CuraGen Announces Second Quarter 1999 Financial Results   Jul 28, 99 17:12 ET V.I. Technologies to Merge with Pentose Pharmaceuticals   08:30 ET International Isotopes Develops Pre-Production High Quality I-123   08:30 ET Lexicon Genetics Announces Agreement With Millennium Pharmaceuticals   08:29 ET Aastrom Biosciences Enters Distribution Agreements With Gambro A/S And Micromin AG for AastromReplicell(TM) System   07:59 ET OXiGENE Reports Second Quarter 1999 Financial Results   Jul 27, 99 10:58 ET Cardiac Science Establishes Middle Eastern Distribution Channels For Powerheart(R) Fully Automatic Defibrillator Monitor   Jul 26, 99 16:31 ET Aquila Biopharmaceuticals Reports Financial Results For the Second Quarter of 1999   08:29 ET New GBC-590 Phase I Data Confirm Earlier Studies   Jul 23, 99 09:15 ET Cambridge NeuroScience Reports Second Quarter 1999 Financial Results   08:06 ET BioMarin Pharmaceutical Inc. Makes Initial Public Offering of Common Stock   Jul 22, 99 17:00 ET EPIX Medical Reports Second Quarter 1999 Results   Jul 21, 99 19:09 ET LeukoSite Completes Acquisition of ProScript, Inc.; Raises $14.4 Million in Private Placement   16:31 ET Aquila Closes Direct Limited Placement   07:00 ET ArQule Announces Combinatorial Chemistry Partnership with Pfizer - Collaboration Worth Up to $117 Million -      06:59 ET ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 1999   Jul 20, 99 09:41 ET Cardiac Science Provides Update on HeartSine Technologies Inc. Acquisition   Jul 19, 99 12:41 ET International Isotopes Inc Obtains Exclusive License For Palladium-103 Brachytherapy Seeds   08:29 ET Aquila and University of Wisconsin Initiate Pivotal Product Licensing Studies of Quilvax-M(TM)   07:59 ET OXiGENE Reports Data on Cellular Mechanism of Action for CA4P at British Scientific Meetings   Jul 15, 99 10:29 ET SafeScience, Inc. Hosts First World Brand Conference   06:59 ET International Isotopes Updates Investors On 1999 Financial Expectations and Corporate Strategy   Jul 14, 99 08:29 ET Aastrom Biosciences Awarded NIH Grant for Expanding Hematopoietic Cells to Accelerate Platelet Recovery   06:59 ET ChiRex Reports Financial Results for Second-Quarter and First-Half 1999   Jul 13, 99 10:44 ET Hepatitis C Patients and Health Care Providers Now Able to Access Customized Information   08:31 ET SafeScience, Inc. Added to the Russell 3000 Index   08:30 ET AltaRex Announces OvaRex(TM) MAb Clinical Progress   Jul 12, 99 08:31 ET ChiRex Appoints Former Schering Plough Vice President of Chemical Development, Bruce P. Shutts As Vice President, Development Operations   Jul 08, 99 08:39 ET Aastrom Biosciences Highlights Stem Cell Expansion Study In Proceedings of the National Academy of Sciences   08:29 ET Pentose Pharmaceuticals Appoints John R. Chapman, Ph.D., as Vice President of Blood Products Research   Jul 07, 99 08:59 ET Afferon to Extend European Phase II Clinical Trials of RTX(TM) With Approvals in UK and France   Jul 06, 99 08:31 ET Dyax Appoints Scott Chappel, Ph.D., as Senior Vice President, Research   Jun 29, 99 09:01 ET Domain Pharma Corporation Adding Web Capabilities to its Clintrial(TM) 4 Clinical Data Management Solutions   Jun 28, 99 08:30 ET Therion Completes $10.5 Million Financing to Accelerate Cancer Vaccine Development   08:29 ET Cardiac Science and Medtronic Physio-Control Sign European Distribution Agreement for Powerheart(R) ECD(TM)   Jun 24, 99 08:59 ET SafeScience's Lectin Inhibitor Stabilizes PSA in Advanced Stage Cancer Patients   08:33 ET ICAgen Obtains Exclusive Rights to Ion Channel Disease Targets From the Research Foundation of State University of New York's Stony Brook Campus   08:29 ET Apoptogen Discovers Novel Cellular Pathway for Anti-Apoptosis Protein Production   08:29 ET Lexicon Genetics Announces Rapid New Method for Accelerating Drug Discovery   Jun 23, 99 06:59 ET LeukoSite to Acquire ProScript and Raise $14.4 Million in Private Placement   Jun 22, 99 11:11 ET Domain Pharma Announces Appointment of Webb Stacy, Ph.D., as Vice President of Development   Jun 21, 99 16:15 ET EPIX Medical and Mallinckrodt Initiate Phase III Clinical Trial of AngioMARK   Jun 16, 99 03:00 ET OXiGENE and Active Biotech Enter Research Collaboration to Develop Anti-Inflammatory Therapeutics   Jun 14, 99 06:29 ET Eurona Medical AB Presents Research Results for ACE Responder Assay   Jun 10, 99 08:29 ET Lexicon Genetics Announces Agreement for Knockout Mice With Academic Institutions   Jun 09, 99 08:29 ET CpG ImmunoPharmaceuticals Appoints Ralph Venhaus, M.D., Vice President of Medical Affairs   07:29 ET LeukoSite, Inc. and ILEX Oncology, Inc. to Present CAMPATH(R) Pivotal Phase II Data at European Haematology Meeting   03:00 ET OXiGENE Reports Mechanism Underlying Specificity of Tumor Vascular Targeting of Combretastatin A-4 Prodrug (CA4P)   Jun 08, 99 15:40 ET WRP Corporation Announces Verbal Receipt of Merger Proposal and Appointment of Special Committee   08:59 ET Domain Pharma Announces Clintrace(TM) Upgrade   08:29 ET Cardiac Science Establishes South American Distribution Channels for Powerheart(R) Fully Automatic Defibrillator Monitor   Jun 07, 99 09:10 ET SafeScience Partners with Southern Africa's Leading Agrochemical Distributor to Enter Growing Continental Agbio Market   Jun 04, 99 18:47 ET Aquila Biopharmaceuticals Files for Registration of Common Stock   Jun 03, 99 09:59 ET AutoImmune Inc. Board of Directors Elects President and CEO Robert C. Bishop as Chairman   08:59 ET International Isotopes Inc Closes Private Equity Financing < Product Sales Expected to Increase Throughout 1999 >   08:29 ET Aastrom Initiates Plans for Capital and Operational Expansion   Jun 02, 99 10:00 ET AltaRex Appoints Marlene R. Booth as Vice President, Regulatory Affairs and Project Management   09:01 ET TerraGen Announces Second Collaboration with Schering-Plough Research Institute to Discover Novel Anti-Infective Drugs   07:59 ET Lexicon Genetics Launches Internet-Based Genomics Database   Jun 01, 99 15:45 ET Instrumentation Laboratory Announces Fiscal 1998 Results   14:12 ET AltaRex Announces Closing of Additional C$5.3 Million Under Its Equity Financing   08:31 ET ImmunoGen, Inc. Receives Second Milestone Payment from SmithKline Beecham as Part of Colorectal Cancer Treatment Agreement   May 27, 99 16:31 ET International Isotopes Inc Announces First Quarter Financial Results and Equity Financing   08:10 ET Perstorp AB Makes Offer to Acquire Endogen, Inc.   May 26, 99 10:00 ET Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect